General examination and investigation of persons without complaint and reported diagnosis

Z21_GENERAL_EXAM_INVES_PERSONS_WO_COMPLA_REPOR_DIAGNOSIS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Z00 Cause of death: ICD-10 — Z00 2 out of 7 registries used, show all original rules.	70568
4. Check minimum number of events None	70568
5. Include endpoints None	70568
6. Filter based on genotype QC (FinnGen only)	63736

Control definitions (FinnGen only)

Control exclude: Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_EXAM_INVES

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: Z[0-1]

NAME	Z21_GENERAL_EXAM_INVES_PERSONS_WO_COMPLA_REPOR_DIAGNOSIS
CONTROL_EXCLUDE	Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_EXAM_INVES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Z00
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Z00
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to General examination and investigation of persons without complaint and reported diagnosis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	63736	40196	23540
Unadjusted period prevalence (%)	12.99	14.27	10.79
Median age at first event (years)	47.84	44.10	54.23

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
43074: Matched controls
223570

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

XKD00

NOMESCO Finland

Uroflowmetry

1.9

323.3

5253

15209

M01AC06

ATC

meloxicam; systemic, rectal

1.6

321.7

12039

44075

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

320.7

19711

80467

R1250, ,

SPAT

3.6

319.2

1371

2050

A10AE04

ATC

insulin glargine; parenteral

2.3

316.8

3115

7431

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.0

316.1

4582

12745

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

315.6

14538

55748

XG410

NOMESCO Finland

Flow-volume spirometry

3.9

315.3

1180

1589

SPAT1059

SPAT

Spirometry at the office

2.9

315.0

1829

3333

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.3

314.6

3018

7120

H03AA01

ATC

levothyroxine sodium; systemic

1.7

314.2

7474

24326

A46

ICD-10 Finland

Erysipelas

1.9

313.5

5177

15061

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.8

313.2

1934

3653

DAX08

NOMESCO Finland

Fitting of hearing aid

3.1

312.5

1691

2952

M01AE02

ATC

naproxen; oral, rectal

1.5

312.4

21107

87680

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.9

312.3

763

686

R55

ICD-10 Finland

Syncope and collapse

2.1

310.2

3854

10119

E66.01

ICD-10 Finland

Obesity due to excess calories

2.1

309.6

3555

9048

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

309.4

14842

57354

PLAK2, ,

NOMESCO Finland

11.3

309.4

483

225

A98

ICPC

Health maint/preventive medicine

2.2

308.7

40399

195569

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

28.8

307.7

472

N06AB04

ATC

citalopram; systemic

2.6

307.7

9152

20784

N05CF02

ATC

zolpidem; oral

2.1

307.7

6477

17646

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.2

307.7

5873

14923

L01

ICPC

Neck symptom/complaint

2.1

307.7

6168

16752

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

5.0

307.7

5321

6177

A01

ICPC

Pain general/multiple sites

2.5

307.7

3711

8104

Z51.0

ICD-10 Finland

Radiotherapy session

8.6

307.7

753

463

SPAT1301

SPAT

No procedures

2.2

307.7

13267

37327

XCK00

NOMESCO Finland

Perimetry

3.6

307.7

2015

3039

R52.2

ICD-10 Finland

Other chronic pain

4.7

307.7

1684

1899

R50.9

ICD-10 Finland

Fever, unspecified

2.3

307.7

6358

15866

SFA30

NOMESCO Finland

Three-surface restoration

1.6

307.7

15543

59391

N06AB03

ATC

fluoxetine; oral

2.7

307.7

5098

10747

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

3.0

307.7

2597

4664

N05BA04

ATC

oxazepam; oral

2.8

307.7

12529

28894

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

500.7

307.7

3214

Z01.1

ICD-10 Finland

Examination of ears and hearing

9.0

307.7

5676

3688

SPAT1263

SPAT

Sampling

2.0

307.7

17462

56139

DFF15

NOMESCO Finland

Speech audiometry

6.9

307.7

1800

1405

KHV, ,

NOMESCO Finland

14.3

307.7

515

189

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

24.5

307.7

577

124

A02BC02

ATC

pantoprazole; systemic

2.1

307.7

27442

100539

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.6

307.7

13128

48899

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

307.7

20491

82280

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

8.4

307.7

783

493

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

6.7

307.7

757

595

P15

ICPC

Chronic alcohol abuse

3.7

307.7

1477

2099

N03AX12

ATC

[U] gabapentin; oral

3.1

307.7

6823

12721

WZC00, ,

SPAT

2.1

307.7

6472

17550

A02BC03

ATC

lansoprazole; oral

1.8

307.7

9689

30602

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.4

307.7

4913

11190

F60.9

ICD-10 Finland

Personality disorder, unspecified

7.0

307.7

688

516

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

4.4

307.7

2223

2731

SAA02

NOMESCO Finland

Basic examination of mouth

1.7

307.7

27551

112987

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.7

307.7

9836

33766

-1, ,

NOMESCO Finland

2.1

307.7

14582

43039

F31.8

ICD-10 Finland

Other bipolar affective disorders

7.1

307.7

1077

809

N05BA12

ATC

alprazolam; oral

2.4

307.7

3697

8257

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.7

307.7

3030

6079

A02BC05

ATC

esomeprazole; systemic

1.8

307.7

14790

49807

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

6.5

307.7

881

715

UJF30

NOMESCO Finland

Ileoscopy through colon

2.4

307.7

3181

7062

WZC30, ,

SPAT

2.7

307.7

3996

8141

R53

ICD-10 Finland

Malaise and fatigue

2.2

307.7

10748

29678

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

307.7

16541

56014

ZX120

NOMESCO Finland

Intravenous

2.9

307.7

3585

6770

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.2

307.7

2913

4986

H13

ICPC

Plugged feeling ear

1.9

307.7

6962

20514

X58

ICD-10 Finland

Exposure to other specified factors

2.0

307.7

5874

16663

R52.9

ICD-10 Finland

Pain, unspecified

2.4

307.7

4029

9274

N06AA09

ATC

amitriptyline; systemic

2.9

307.7

3490

6501

WX290

NOMESCO Finland

Other blockage of nerve

1.6

307.7

19175

74728

IGY02

NOMESCO Finland

Psychiatric monitoring contact

5.4

307.7

1899

1900

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

9.6

307.7

827

456

TQW80

NOMESCO Finland

Local dermatologic skincare

5.5

307.7

1282

1232

Z2445

NOMESCO Finland

Psychologist

4.6

307.7

2002

2325

XCW99

NOMESCO Finland

Other investigative procedure of eye

3.8

307.7

4477

6637

N05AX08

ATC

risperidone; systemic

2.9

307.7

4064

7681

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

19.6

307.7

1208

328

XA402

NOMESCO Finland

ENMG

13.3

307.7

1103

440

N02BE01

ATC

paracetamol; systemic, rectal

2.7

307.7

37453

159167

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.1

307.7

3984

10289

N05AH03

ATC

olanzapine; systemic

4.6

307.7

3876

4670

P99

ICPC

Psychological disorders other

5.3

307.7

1835

1869

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

307.7

9446

29912

J02AC01

ATC

fluconazole; systemic

1.6

307.7

13396

48122

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.1

307.7

3843

6774

N05AX12

ATC

aripiprazole; systemic

5.1

307.7

2543

2716

U02

ICPC

Urinary frequency/urgency

2.1

307.7

5153

13625

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.2

307.7

1941

3294

Z00.6

ICD-10 Finland

Examination for normal comparison and control in clinical research programme

34.1

307.7

1393

219

N03AX16

ATC

[U] pregabalin

2.6

307.7

9234

20958

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.9

307.7

11094

35182

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

6.1

307.7

1253

1097

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

307.7

7720

21712

N06AX26

ATC

vortioxetine; oral

3.1

307.7

3871

6844

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

6.6

307.7

1330

1067

SPAT1312

SPAT

General health counselling

1.7

307.7

12426

42291

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.9

307.7

17102

58551

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.7

307.7

8431

27882

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.2

307.7

4954

12430

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

6.3

307.7

1282

1081

L15

ICPC

Knee symptom/complaint

1.7

307.7

8811

29181

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.5

307.7

2289

3506

F61.0

ICD-10 Finland

Mixed personality disorders

7.3

307.7

959

691

N06AB10

ATC

escitalopram; oral

2.6

307.7

9905

23184

A10AB05

ATC

insulin aspart; parenteral

2.7

307.7

2683

5368

R07.4

ICD-10 Finland

Chest pain, unspecified

2.2

307.7

10911

29456

N05AA02

ATC

levomepromazine; systemic

3.6

307.7

1834

2712

R03AC02

ATC

salbutamol; inhalant

1.8

307.7

21775

80065

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.4

307.7

3043

6863

Z01.8

ICD-10 Finland

Other specified special examinations

9.4

307.7

9762

6753

H02AB06

ATC

prednisolone; systemic

1.9

307.7

18444

62643

R02

ICPC

Shortness of breath/dyspnoea

2.3

307.7

4978

12222

SPAT1283

SPAT

Restricted health certificate

1.8

307.7

7026

22198

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

23.2

307.7

2331

551

N06AX21

ATC

duloxetine; oral

3.5

307.7

5670

9287

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

21.2

307.7

2485

645

N06BA04

ATC

methylphenidate; oral

4.0

307.7

1805

2407

R42

ICD-10 Finland

Dizziness and giddiness

2.2

307.7

8931

23313

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

6.0

307.7

941

833

SPAT1249

SPAT

Treatment-related counselling outside office

2.2

307.7

17280

52035

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.3

307.7

2248

3664

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

6.6

307.7

1611

1306

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

307.7

9660

31461

SAA01

NOMESCO Finland

Simple examination of mouth

2.0

307.7

30354

121079

XG474

NOMESCO Finland

Exhalation nntrogen oxide

5.4

307.7

1035

1010

SPAT1273

SPAT

Structured assessment of psychoactive substance / tobacco use

3.3

307.7

1774

2903

HMAK, ,

NOMESCO Finland

2.9

307.7

5882

11747

M79.1

ICD-10 Finland

Myalgia

2.0

307.7

5527

15026

J01MA02

ATC

ciprofloxacin; systemic

1.7

307.7

14084

49063

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

6.0

307.7

5427

5262

SFA10

NOMESCO Finland

One-surface restoration

1.7

307.7

22335

85988

R5140

NOMESCO Finland

Monitoring the use of the aid

2.4

307.7

4265

9700

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

3.5

307.7

3843

6121

R11

ICD-10 Finland

Nausea and vomiting

2.6

307.7

3521

7327

UJF32

NOMESCO Finland

Coloscopy

2.4

307.7

9077

22754

RF410, ,

NOMESCO Finland

17.7

307.7

877

262

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

5.7

307.7

2669

2542

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

307.7

8582

27434

Z01.0

ICD-10 Finland

Examination of eyes and vision

18.0

307.7

7291

2502

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

7.9

307.7

1474

995

R5110, ,

SPAT

2.6

307.7

2955

6222

A03

ICPC

Fever

1.8

307.7

6925

21321

F32.9

ICD-10 Finland

Depressive episode, unspecified

4.1

307.7

7771

11515

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

4.9

307.7

3955

4522

L03

ICPC

Low back symptom/complaint

2.0

307.7

11809

34812

Z04.3

ICD-10 Finland

Examination and observation following other accident

64.4

307.7

756

T89

ICPC

Diabetes insulin dependent

3.7

307.7

1420

2054

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.8

307.7

11297

37244

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

12.7

307.7

5047

2312

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

3.3

307.7

5725

9817

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.1

307.7

5189

13967

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

7.5

307.7

1124

799

M03BX02

ATC

tizanidine; oral

1.6

307.7

23542

95795

Z00.8

ICD-10 Finland

Other general examinations

11.0

307.7

8195

4683

SPAT1240

SPAT

Therapeutic discussion

3.2

307.7

5501

9737

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.0

307.7

2542

4588

R05

ICPC

Cough

1.9

307.7

9555

29040

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

6.0

307.7

1922

1726

N06AX22

ATC

agomelatine; oral

5.2

307.7

1176

1201

K02.1

ICD-10 Finland

Caries of dentine

1.7

307.7

24423

96461

L28

ICPC

Limited function/disability (L)

2.5

307.7

7410

16854

R96

ICPC

Asthma

2.3

307.7

3371

8101

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

5.9

307.7

1472

1341

N06AX16

ATC

venlafaxine; oral

3.4

307.7

7259

12606

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

13.1

307.7

1444

589

R4110, ,

SPAT

2.4

307.7

5109

12023

R51.80

ICD-10 Finland

Headache

2.9

307.7

7158

14217

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.4

307.7

3619

8182

P06

ICPC

Sleep disturbance

2.1

307.7

5299

13953

A04

ICPC

Weakness/tiredness general

2.3

307.7

6406

15839

N06AB05

ATC

paroxetine; oral

2.9

307.7

2448

4526

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.9

307.7

1356

1850

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.1

307.7

9269

25753

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.6

307.7

4381

9229

R21

ICPC

Throat symptom/complaint

1.8

307.7

8746

27609

Z02.7

ICD-10 Finland

Issue of medical certificate

2.5

307.7

2996

6533

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.9

307.7

6352

18365

M48.0

ICD-10 Finland

Spinal stenosis

2.1

307.7

3830

9778

SPAT1325

SPAT

Vaccination

1.6

307.7

11729

42014

WZA90

NOMESCO Finland

Other medical or dental certificate

1.8

307.7

8829

28142

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.1

307.7

5720

15528

M25.5

ICD-10 Finland

Pain in joint

1.8

307.7

12289

40492

A06AD11

ATC

lactulose; oral

2.0

307.7

5070

13880

N05BA01

ATC

diazepam; systemic, rectal

2.7

307.7

5497

11673

N02BF01

ATC

gabapentin; oral

2.5

307.7

3877

8471

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

307.7

28450

121963

JN3AD

NOMESCO Finland

Abdominal CT examination

2.0

307.7

4583

12462

N06AX11

ATC

mirtazapine; oral

2.6

307.7

15869

40689

P74

ICPC

Anxiety disorder/anxiety state

3.3

307.7

2212

3586

N06AX12

ATC

bupropion; oral

3.4

307.7

3887

6321

J01EA01

ATC

trimethoprim; systemic

1.7

307.7

8619

28018

PLAK1, ,

NOMESCO Finland

10.6

307.7

731

365

N06AX05

ATC

trazodone; oral

4.6

307.7

1084

1250

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

31.8

307.7

455

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.3

307.7

13587

37487

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.8

307.7

9024

28995

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.6

307.7

4061

8737

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

4.6

307.7

4603

5690

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

6.6

307.7

1526

1246

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.8

307.7

7738

24260

Z01.2

ICD-10 Finland

Dental examination

1.6

307.7

18129

69374

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

3.7

307.7

1509

2149

SPAT1131

SPAT

Colonoscopy

4.6

307.7

1542

1806

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

2.7

307.7

5010

10539

Z97.4

ICD-10 Finland

Presence of external hearing-aid

6.8

307.7

1755

1383

J45.9

ICD-10 Finland

Asthma, unspecified

2.3

307.7

7240

18333

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

3.0

307.7

2292

4173

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

6.3

307.7

1949

1663

J01DB01

ATC

cefalexin; oral

2.2

307.7

34415

144886

F34.1

ICD-10 Finland

Dysthymia

4.4

307.7

1787

2157

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.0

307.7

9216

26932

R5599

NOMESCO Finland

Other rehabilitation service

4.6

307.7

1131

1301

Z29

ICPC

Social problem NOS

4.5

307.7

1026

1193

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.2

307.7

6854

17812

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.7

307.7

6132

13102

R1250

NOMESCO Finland

Evaluation of functional capability

4.9

307.7

1206

1307

N05AH04

ATC

quetiapine; oral

3.8

307.7

10342

17132

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

12.1

307.7

1536

679

EBA00

NOMESCO Finland

Extraction of tooth

1.7

307.7

14830

52704

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.1

307.7

3286

5768

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

307.7

11633

37704

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

6.8

307.7

2054

1643

F90.0

ICD-10 Finland

Disturbance of activity and attention

4.0

307.7

2075

2793

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

3.0

307.7

5184

9815

D01

ICPC

Abdominal pain/cramps general

2.0

307.7

4474

12117

N02AX02

ATC

tramadol; systemic, rectal

2.0

307.7

16846

54315

P76

ICPC

Depressive disorder

3.4

307.7

3476

5560

P01

ICPC

Feeling anxious/nervous/tense

2.6

307.7

6473

14282

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

3.2

307.7

1936

3223

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.4

307.7

15977

44248

N02BF02

ATC

pregabalin; oral

2.8

307.7

2597

4936

N03AG01

ATC

valproic acid; systemic, rectal

4.2

307.7

3145

4116

R5120

NOMESCO Finland

Preparation of an aid

7.1

307.7

1242

935

T36

ICD-10 Finland

Poisoning by systemic antibiotics

6.0

307.7

2564

2336

DFF00

NOMESCO Finland

Pure tone audiometry

4.4

307.7

3627

4549

M54.5

ICD-10 Finland

Low back pain

2.1

307.7

15588

47023

N05AN01

ATC

lithium; oral

5.2

307.7

1230

1260

RF120, ,

NOMESCO Finland

9.4

307.7

624

348

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

6.5

307.7

1204

991

A03FA01

ATC

metoclopramide; systemic, rectal

1.8

307.7

7768

24784

N03AX09

ATC

lamotrigine; oral

5.6

307.7

2766

2722

R06.0

ICD-10 Finland

Dyspnoea

2.3

307.7

10547

27984

J01AA02

ATC

doxycycline; systemic

1.7

307.7

29677

127698

Z3229

NOMESCO Finland

Other healthcare associate professional

2.9

307.7

3119

5883

SPAT1310

SPAT

Counselling related to known health issue

2.2

307.7

13584

38507

N05CF01

ATC

zopiclone; oral

2.2

307.7

12960

37188

N30.0

ICD-10 Finland

Acute cystitis

2.0

307.7

6269

17544

ZYC01

NOMESCO Finland

Remote contact by phone

5.1

307.7

4108

4493

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.8

307.7

18772

66587

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

28.6

307.7

1312

245

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.4

307.7

3541

8045

N05CD07

ATC

temazepam; oral

2.1

307.7

4065

10558

WZC00

NOMESCO Finland

Treatment plan or consultation

1.9

307.7

14834

48771

XQ800

NOMESCO Finland

Prick test

4.5

307.7

2465

2976

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

7.1

307.7

772

573

RD211, ,

NOMESCO Finland

13.8

307.7

3645

1491

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.9

307.7

2673

4952

G44.2

ICD-10 Finland

Tension-type headache

2.3

307.7

5350

12728

M79.6

ICD-10 Finland

Pain in limb

2.0

307.7

17624

58114

N07BB01

ATC

disulfiram; oral

3.3

307.7

2008

3278

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.3

307.7

3251

7689

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

4.4

307.7

2229

2741

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.1

307.7

8412

23447

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

4.8

307.7

1165

1297

SPAT1097

SPAT

Recording of ECG

2.2

307.7

4869

12286

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.1

307.7

4692

12171

SPAT1360

SPAT

Extensive global examination

3.2

307.7

2949

4969

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

5.7

307.7

1532

1428

F43.1

ICD-10 Finland

Post-traumatic stress disorder

4.5

307.7

1265

1509

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.5

307.7

4985

10992

RF420, ,

NOMESCO Finland

12.5

307.7

904

383

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.5

307.7

11598

29167

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

4.6

307.7

1366

1569

M79.7

ICD-10 Finland

Fibromyalgia

4.6

307.7

1347

1546

SPAT1254

SPAT

Administration of medicine

2.6

307.7

6455

14307

R03DC03

ATC

montelukast; oral

1.9

307.7

5756

16689

SPAT1307

SPAT

Psychosocial counselling and guidance

3.1

307.7

3129

5476

E0000UV, ,

ATC

1.7

307.7

15848

57736

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

307.7

17046

58943

IGY99

NOMESCO Finland

Other psychiatric treatment contact

6.5

307.7

1331

1095

R06AE07

ATC

cetirizine; oral

1.6

307.7

16234

62024

M54.4

ICD-10 Finland

Lumbago with sciatica

2.1

307.7

7088

18811

F29

ICD-10 Finland

Unspecified nonorganic psychosis

4.3

307.7

1979

2487

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

7.2

307.7

745

545

N05AF03

ATC

chlorprothixene; systemic

4.4

307.7

1278

1532

C07AB07

ATC

bisoprolol; oral

1.8

307.7

17385

60631

AA1AD

NOMESCO Finland

CT of head and brain

2.0

307.7

10455

30335

Z08

ICPC

Social welfare problem

7.8

307.7

754

508

Z00.0

ICD-10 Finland

General medical examination

19.2

307.7

23470

13124

SPAT1153

SPAT

Removal of sutures

2.1

307.7

11996

35092

UKC02

NOMESCO Finland

Cystoscopy

2.2

307.7

5660

14396

XCH00

NOMESCO Finland

Eye pressure measurement

4.2

307.7

1595

2042

SPAT1216

SPAT

Assessment of functional ability

3.4

307.7

6999

11908

SPAT1234

SPAT

Support of social functional capacity

3.4

307.7

2159

3370

S15

ICPC

Foreign body in skin

2.8

307.7

2668

5201

SPAT1359

SPAT

Use of symptom diary

9.7

307.7

1625

902

N06AB06

ATC

sertraline; oral

3.0

307.7

5499

10517

J01CA04

ATC

amoxicillin; systemic

1.6

307.7

32962

149215

R07.3

ICD-10 Finland

Other chest pain

2.3

307.7

3744

8758

ZY010

NOMESCO Finland

Hospital outpatient

5.0

307.7

3047

3357

P29

ICPC

Psychological sympt/compl other

3.8

307.7

4436

6604

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

13.0

307.7

617

250

J45.8

ICD-10 Finland

Mixed asthma

4.3

307.7

1262

1567

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

4.8

307.7

2008

2232

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

4.9

307.7

1069

1148

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.3

307.7

3347

7869

KMAK, ,

NOMESCO Finland

1.7

307.7

20211

75219

EB1VA, ,

NOMESCO Finland

1.9

307.7

7018

20945

F51.0

ICD-10 Finland

Nonorganic insomnia

2.2

307.7

7291

19352

C07AA05

ATC

propranolol; systemic

2.2

307.7

8194

21514

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

5.6

307.7

3452

3421

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

307.7

5939

17393

P01AB01

ATC

metronidazole; oral, rectal

1.7

307.7

14242

50865

IBZ06

NOMESCO Finland

Evaluation concerning developmental neuropsychiatry

19.0

307.7

410

113

XQ802

NOMESCO Finland

Epicutan test

5.6

307.7

1106

1056

P03

ICPC

Feeling depressed

3.0

307.7

5260

9940

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

4.6

307.7

1396

1613

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

7.5

307.7

1162

819

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

307.7

7968

24929

L17

ICPC

Foot/toe symptom/complaint

1.8

307.7

11151

36157

N05BE01

ATC

buspirone; oral

4.1

307.7

1267

1650

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

221.0

307.7

16912

652

G47.3

ICD-10 Finland

Sleep apnoea

1.9

307.7

8482

25893

K30

ICD-10 Finland

Functional dyspepsia

2.1

307.7

3921

10122

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

3.0

307.7

3003

5496

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

2.0

307.7

12395

37248

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.9

307.7

8175

24312

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

307.7

16524

58656

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

5.5

307.7

2356

2336

A28

ICPC

Limited function/disability NOS

1.9

307.7

5535

16112

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.6

307.7

3066

6510

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

6.9

307.7

1098

848

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.5

307.7

5193

11832

J01FF01

ATC

clindamycin; systemic

1.8

307.7

9898

31799

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

10.3

307.7

4559

2548

SAA03

NOMESCO Finland

Extended examination of mouth

1.8

307.7

15686

53240

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

7.2

307.7

716

521

S18

ICPC

Laceration/cut

2.1

307.7

19031

61080

L08

ICPC

Shoulder symptom/complaint

1.8

307.7

8097

25801

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

86.1

307.7

1766

111

R13

ICD-10 Finland

Dysphagia

2.6

307.7

2346

4759

N03AE01

ATC

clonazepam; systemic

3.7

307.7

2444

3591

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.7

307.7

10359

35215

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

5.7

307.7

2793

2710

G43.9

ICD-10 Finland

Migraine, unspecified

2.7

307.7

2421

4854

F99

ICD-10 Finland

Mental disorder, not otherwise specified

5.4

307.7

1036

1010

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.8

307.7

11080

24923

K59.09

ICD-10 Finland

Constipation, unspecified

2.9

307.7

2555

4691

R60.0

ICD-10 Finland

Localized oedema

2.1

307.7

4360

11332

SFA20

NOMESCO Finland

Two-surface restoration

1.6

307.7

23201

93252

Z3231

NOMESCO Finland

Registered nurse

2.4

307.7

11509

29143

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.8

307.7

22278

82433

WZC30

NOMESCO Finland

Teaching

2.7

307.7

7561

16502

F39

ICD-10 Finland

Unspecified mood [affective] disorder

5.5

307.7

978

948

M79.0

ICD-10 Finland

Rheumatism, unspecified

4.3

307.7

1108

1364

SPAT1260

SPAT

Consultation of another employee

2.1

307.7

6888

18641

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

39.8

307.7

805

107

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

8.9

307.7

8301

5841

N02AA05

ATC

oxycodone; systemic

2.3

307.7

6976

17397

C03CA01

ATC

furosemide; systemic

1.7

307.7

9956

32788

SPAT1252

SPAT

Overall medication plan or its review

5.6

307.7

3830

3835

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

4.1

307.7

1201

1553

XA800

NOMESCO Finland

Neuropsychological investigation

3.2

307.7

1632

2705

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

7.0

307.7

1094

828

A29

ICPC

General symptom/complaint other

2.2

307.7

4929

12301

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

6.1

307.7

1025

895

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.3

307.7

4635

11020

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

307.7

7449

20704

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.9

307.7

5382

10322

OAB71, ,

SPAT

10.4

307.7

547

276

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

6.5

307.7

2310

1926

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.4

307.7

1467

2268

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

46.4

307.7

1461

169

S29

ICPC

Skin symptom/complaint other

1.8

307.7

7319

22524

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

9.6

307.7

1039

573

S06.0

ICD-10 Finland

Concussion

2.4

307.7

4543

10280

Z71.8

ICD-10 Finland

Other specified counselling

2.6

307.7

16422

43005

F41.1

ICD-10 Finland

Generalized anxiety disorder

3.5

307.7

2770

4343

SPAT1229

SPAT

Assessment of need for aid

3.1

307.7

2806

4987

N06AX03

ATC

mianserin; oral

3.1

307.7

1776

3076

R83

ICPC

Respiratory infection other

1.7

307.7

10550

35689

Z2446

NOMESCO Finland

Social worker

2.5

307.5

2381

5076

R20.2

ICD-10 Finland

Paraesthesia of skin

2.4

307.3

2575

5706

T90

ICPC

Diabetes non-insulin dependent

1.7

306.4

7737

25582

N05AB03

ATC

perphenazine; systemic, rectal

3.3

305.8

1473

2385

R01AD09

ATC

mometasone; nasal

1.5

305.5

16360

64672

J01DA01

ATC

[U] cefalexin

1.5

303.8

22891

96982

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.1

301.5

3751

9849

M54.2

ICD-10 Finland

Cervicalgia

2.3

301.5

2872

6751

R05

ICD-10 Finland

Cough

1.7

301.1

7368

24138

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

300.8

4600

13024

R00.2

ICD-10 Finland

Palpitations

2.3

300.4

2822

6592

N05BA06

ATC

lorazepam; systemic, sublingual

2.7

299.6

1977

3874

A05

ICPC

Feeling ill

2.4

299.4

2483

5473

H01

ICPC

Ear pain/earache

2.0

299.0

4406

12313

AN1

Coronary angiography

2.2

298.9

3342

8409

F41.00

ICD-10 Finland

Moderate panic disorder

5.7

298.8

748

691

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.2

298.7

3238

8045

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.9

297.7

4664

13313

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

295.6

7728

25765

M54.6

ICD-10 Finland

Pain in thoracic spine

2.3

295.3

2759

6427

R74

ICPC

Upper respiratory infection acute

1.5

294.8

12696

47791

R35

ICD-10 Finland

Polyuria

2.5

294.7

2369

5142

L16

ICPC

Ankle symptom/complaint

2.0

293.0

4289

11953

M01AH05

ATC

etoricoxib; oral

1.5

292.8

22858

97207

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

3.2

292.0

1442

2373

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.2

291.9

1462

2428

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.7

290.2

1995

3996

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

290.0

13823

53151

L13

ICPC

Hip symptom/complaint

1.8

289.2

6067

18994

B01AB05

ATC

enoxaparin; parenteral

1.6

288.8

9972

35645

U04

ICPC

Incontinence urine

2.7

287.5

1957

3899

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

287.4

6679

21536

ZYC03

NOMESCO Finland

Remote contact, text-based

12.1

286.0

431

187

AN2

Balloon angioplasty, including several vessels

3.8

285.4

1106

1530

P20

ICPC

Memory disturbance

2.0

284.1

4073

11260

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.3

284.1

2596

5984

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

7.6

283.8

561

386

P25

ICPC

Phase of life problem adult

2.8

283.6

1788

3414

R03BA01

ATC

beclometasone; inhalant

1.9

283.3

4744

13833

A02BC01

ATC

omeprazole; systemic

1.6

283.3

9136

32098

TAB00

NOMESCO Finland

Lumbar puncture

3.1

282.3

1525

2657

D11

ICPC

Diarrhoea

1.9

281.7

4386

12479

Z11

ICPC

Compliance/being ill problem

12.7

281.1

414

171

F10.20

ICD-10 Finland

Alcohol dependence currently independent

4.2

280.6

954

1186

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

4.5

280.4

882

1024

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.1

280.0

3353

8663

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

5.2

279.5

769

785

PLAK0, ,

NOMESCO Finland

8.7

278.8

505

305

L12

ICPC

Hand/finger symptom/complaint

1.7

276.2

6029

19073

SPAT1255

SPAT

Intravenous administration of medicine

2.4

274.3

2318

5150

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.7

273.8

6533

21193

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.7

273.7

1101

1567

F43.00

ICD-10 Finland

Acute stress reaction mild

3.8

273.3

1068

1487

A02BA02

ATC

ranitidine; systemic

1.8

273.2

5861

18443

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.5

272.4

2177

4708

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

6.5

271.8

605

487

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.1

270.9

3215

8273

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

270.3

7629

25879

D07AC01

ATC

betamethasone; topical

1.5

270.2

12709

48556

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

2.0

269.7

3640

9836

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

269.2

8525

29764

IHZ05

NOMESCO Finland

Therapeutic conversation

15.7

268.9

362

121

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

4.4

268.2

869

1036

N01

ICPC

Headache

1.9

267.9

4213

12015

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

267.6

20526

86359

B01AC04

ATC

clopidogrel; oral

1.8

266.5

4875

14608

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.7

266.4

6796

22436

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.0

266.2

3605

9751

M70.6

ICD-10 Finland

Trochanteric bursitis

1.9

264.7

3943

11035

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.8

264.3

4788

14301

OAB50

NOMESCO Finland

Delivery of care equipment and instruction on their use

6.5

264.2

589

475

SPAT1262

SPAT

Handing over of treatment supplies

1.8

264.2

5598

17538

R01AD01

ATC

beclometasone; nasal

1.8

263.1

5240

16114

SPAT1053

SPAT

Memory test

1.9

262.8

4075

11562

F32.8

ICD-10 Finland

Other depressive episodes

5.0

262.6

752

799

H04.10

ICD-10 Finland

Dry eye syndrome

1.9

261.1

3841

10700

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.5

261.0

10180

37282

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

260.7

5377

16706

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.6

260.7

9617

34777

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

4.7

260.1

779

864

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.8

259.7

5349

16611

SFA00

NOMESCO Finland

Small restoration

1.8

257.8

4922

14935

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

2.1

257.6

3245

8538

M01AH01

ATC

celecoxib; oral

1.7

257.2

5623

17765

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

4.3

256.7

861

1058

R29

ICPC

Respiratory symptom/complaint other

2.3

255.8

2347

5413

N03AX11

ATC

topiramate; oral

4.0

255.7

938

1242

IHZ05, ,

SPAT

2.5

255.5

2003

4288

E66.8

ICD-10 Finland

Other obesity

2.5

255.0

1970

4187

Z03

ICPC

Housing/neighbourhood problem

10.2

254.9

419

215

J01FA10

ATC

azithromycin; systemic

1.4

254.6

21285

90657

T74.1

ICD-10 Finland

Physical abuse

4.2

253.3

867

1084

A10AB04

ATC

insulin lispro; parenteral

3.8

253.1

997

1396

F41.8

ICD-10 Finland

Other specified anxiety disorders

3.0

252.5

1400

2477

H02AB04

ATC

methylprednisolone; systemic

1.8

251.8

4506

13392

XCK10

NOMESCO Finland

Photography of fundus of eye

2.3

251.6

2276

5215

SPAT1058

SPAT

PEF monitoring instruction

2.2

251.5

2596

6303

IBA03

NOMESCO Finland

Psychotherapy evaluation

7.1

251.0

522

385

Y96.9

ICD-10 Finland

Unspecified type of accident

4.7

251.0

762

856

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.1

250.4

2923

7464

SGA01

NOMESCO Finland

Emergency treatment

1.7

250.2

6203

20287

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.6

249.2

1818

3752

J01MA14

ATC

moxifloxacin; systemic

2.1

247.3

2940

7560

H02

ICPC

Hearing complaint

1.8

247.2

4421

13132

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

247.0

6760

22688

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.0

246.5

3147

8318

L02

ICPC

Back symptom/complaint

1.9

246.4

3729

10480

N03AF01

ATC

carbamazepine; oral, rectal

2.6

245.8

1742

3541

M01AX17

ATC

nimesulide; oral

1.6

245.7

7285

24951

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.9

244.3

4127

12033

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.4

244.3

2101

4701

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.9

244.2

3992

11514

D19

ICPC

Teeth/gum symptom/complaint

1.5

244.2

11421

43387

SPAT1211

SPAT

Application of soft bandage

2.1

244.1

2950

7634

N06AG02

ATC

moclobemide; oral

2.8

243.3

1489

2792

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

243.3

3335

9048

127

Kela drug reimbursment

Transplant complication

5.9

243.0

586

519

N04BC05

ATC

pramipexole; oral

2.3

242.3

2325

5468

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.2

242.1

2569

6308

C08CA13

ATC

lercanidipine; oral

1.8

240.8

4489

13503

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.1

240.7

2935

7620

K04.08

ICD-10 Finland

Other specified pulpit

2.0

240.6

3055

8055

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

4.6

239.9

742

848

K59.1

ICD-10 Finland

Functional diarrhoea

2.5

239.7

1852

3934

WW200, ,

SPAT

1.5

238.8

10595

39769

G04BD12

ATC

mirabegron; oral

1.9

238.8

3521

9801

Z01.7

ICD-10 Finland

Laboratory examination

1.7

238.8

5518

17680

U01

ICPC

Dysuria/painful urination

2.1

238.7

2642

6600

SPAT1043

SPAT

Audiometry

2.1

238.6

2978

7800

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.9

238.1

1408

2588

C10AA01

ATC

simvastatin; oral

1.5

237.6

12552

48820

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

237.3

12215

47262

RF210, ,

NOMESCO Finland

3.4

237.1

1077

1673

N05AH02

ATC

clozapine; systemic

4.0

236.8

862

1134

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.7

236.5

1525

2945

P72

ICPC

Schizophrenia

3.9

236.4

902

1232

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.8

235.3

4067

11939

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

4.4

234.7

771

930

H53.1

ICD-10 Finland

Subjective visual disturbances

2.3

233.7

2281

5402

A10AE05

ATC

insulin detemir; parenteral

2.6

233.3

1628

3281

L29

ICPC

Musculoskeletal sympt/complt other

2.0

233.2

2932

7698

M01AE01

ATC

ibuprofen; systemic, rectal

1.6

233.2

36313

172656

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.5

232.9

10067

37545

J01FA06

ATC

roxithromycin; oral

1.5

232.8

13334

52642

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

9.7

232.4

393

212

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

232.4

3701

10574

K07.60

ICD-10 Finland

Snapping jaw

2.5

232.1

1770

3734

SCA01

NOMESCO Finland

Preventive oral health care, short

1.5

231.8

10943

41563

JN4AD

NOMESCO Finland

Body CT examination

1.9

231.6

3676

10489

R03BA05

ATC

fluticasone; inhalant

1.7

231.4

6064

20090

R07

ICPC

Sneezing/nasal congestion

2.1

230.2

2567

6429

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.5

229.9

1807

3870

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

7.8

229.4

445

298

J01MA12

ATC

levofloxacin; systemic

1.7

228.9

5817

19110

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

228.4

9753

36253

J01CA08

ATC

pivmecillinam; oral

1.5

226.2

12928

50949

IGY02, ,

SPAT

4.2

226.2

774

967

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.9

225.5

3686

10617

F10.24

ICD-10 Finland

Alcohol depence active use

4.5

225.5

716

838

D06

ICPC

Abdominal pain localized other

2.0

225.4

3017

8105

Z71.4

ICD-10 Finland

Alcohol abuse counselling and surveillance

12.8

224.9

329

134

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

224.5

26156

116962

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.7

223.8

5319

17150

T78.4

ICD-10 Finland

Allergy, unspecified

2.7

222.9

1495

2949

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

8.1

222.4

421

272

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.5

220.7

1760

3795

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.2

220.3

2163

5133

N06AA12

ATC

doxepin; systemic

2.6

219.6

1618

3353

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.8

218.7

838

1148

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.5

217.9

1695

3610

XQ848

NOMESCO Finland

Dermatological photography

3.2

217.7

1075

1766

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.6

217.7

1597

3302

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

6.4

217.6

490

400

J45.1

ICD-10 Finland

Nonallergic asthma

2.2

217.4

2203

5299

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

217.0

7557

26807

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.5

216.9

10423

39632

F40.1

ICD-10 Finland

Social phobias

3.2

216.5

1103

1849

K08.80

ICD-10 Finland

Toothache NOS

1.9

216.4

3196

8889

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.1

216.3

2576

6618

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.3

216.2

1022

1631

N03AF02

ATC

oxcarbazepine; oral

3.0

216.1

1183

2075

DFF30

NOMESCO Finland

Loudness discomfort Level (LDL)

4.1

212.9

744

946

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

5.9

212.4

514

457

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

11.0

212.2

334

158

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.1

212.2

2352

5871

N17

ICPC

Vertigo/dizziness

1.8

212.1

3888

11608

SPAT1098

SPAT

Exercise ECG

4.1

210.8

750

968

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

4.3

210.6

696

844

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.1

209.9

2372

5967

ICB06, ,

NOMESCO Finland

7.1

209.2

434

319

R01AD08

ATC

fluticasone; nasal

1.5

209.2

9498

35653

S10

ICPC

Boil/carbuncle

2.2

207.5

2108

5074

A10AB01

ATC

insulin (human); parenteral

3.1

207.0

1072

1816

Z50.1

ICD-10 Finland

Other physical therapy

2.6

206.2

1476

3012

UJF92

NOMESCO Finland

Capsular endoscopy

4.4

206.2

669

798

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.1

206.1

2369

5998

F32

ICD-10 Finland

Depressive episode

2.2

206.1

2087

5016

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.4

205.8

916

1402

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

4.8

205.7

602

653

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.8

205.5

3772

11260

IHZ04, ,

SPAT

3.7

205.5

822

1164

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

6.3

204.5

466

386

R03BA08

ATC

ciclesonide; inhalant

2.0

203.9

2667

7096

SPAT1251

SPAT

Organisation of medication

2.8

203.4

1258

2371

R03BB04

ATC

tiotropium bromide; inhalant

1.9

203.3

3041

8488

K10.3

ICD-10 Finland

Alveolitis of jaws

2.4

203.2

1752

3919

K05

ICPC

Irregular heartbeat other

3.0

202.6

1108

1942

H04AA01

ATC

glucagon; nasal, parenteral

3.9

202.4

751

1003

L04AA06

ATC

mycophenolic acid; systemic

4.4

202.3

655

780

J05AB01

ATC

aciclovir; systemic

1.6

202.1

7048

24960

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.6

202.1

7028

24874

SPAT1243

SPAT

Psychiatric/psychological examination

2.9

200.8

1144

2055

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.7

200.7

805

1142

F32.1

ICD-10 Finland

Moderate depressive episode

2.1

200.0

2300

5823

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.5

199.4

8050

29436

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.1

199.0

1029

1741

P27

ICPC

Fear of mental disorder

4.6

198.4

610

693

R06AX27

ATC

desloratadine; oral

1.5

197.7

9953

38071

A10AC01

ATC

insulin (human); parenteral

2.1

197.3

2310

5889

XX1AD

NOMESCO Finland

Other CT-examination

7.8

197.2

383

257

RD210, ,

NOMESCO Finland

4.4

197.0

643

771

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.8

196.2

767

1067

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.0

196.0

2468

6471

Z71.9

ICD-10 Finland

Counselling, unspecified

2.0

195.3

2719

7396

H02AB09

ATC

hydrocortisone; systemic

3.7

195.2

779

1101

C08CA01

ATC

amlodipine; oral

1.4

194.8

11954

47442

R01AD12

ATC

fluticasone furoate; nasal

1.4

194.5

10997

42985

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.1

193.8

987

1654

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

193.2

3285

9563

M02AA10

ATC

ketoprofen; topical

1.7

193.2

4992

16412

R31

ICD-10 Finland

Unspecified haematuria

1.9

192.5

3240

9401

S22.3

ICD-10 Finland

Fracture of rib

2.0

192.4

2452

6456

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

192.1

4460

14246

J46

ICD-10 Finland

Status asthmaticus

3.2

191.1

949

1564

R12

ICD-10 Finland

Heartburn

1.9

190.9

2822

7838

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

19.4

190.8

238

K03.66

ICD-10 Finland

Tooth plaque

2.0

190.7

2571

6911

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.7

190.5

1225

2359

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

6.3

190.0

437

366

EB1HA, ,

SPAT

3.0

189.5

1034

1809

JAH01

NOMESCO Finland

Laparoscopy

2.5

189.1

1437

3022

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.8

189.1

1174

2217

E000001, ,

ATC

1.6

188.9

6517

22983

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

5.7

188.9

471

433

Z25.1

ICD-10 Finland

Need for immunization against influenza

2.3

188.8

1771

4114

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

188.7

9248

35133

R09

ICPC

Sinus symptom/complaint

1.9

188.6

2728

7519

K59.0

ICD-10 Finland

Constipation

2.2

188.2

1853

4397

H29

ICPC

Ear symptom/complaint other

1.8

187.8

3756

11493

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.7

187.5

1264

2498

-, ,

ICD-10 Finland

3.8

186.5

731

1019

G04BD08

ATC

solifenacin; oral

2.2

186.0

1861

4446

GD1AD

NOMESCO Finland

Thorax CT examination

2.2

185.5

1911

4622

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

3.7

185.0

755

1085

R52.1

ICD-10 Finland

Chronic intractable pain

7.1

184.8

384

283

Z06

ICPC

Unemployment problem

5.9

183.7

447

400

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.5

183.1

1401

2956

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.2

182.8

1795

4253

M01AB05

ATC

diclofenac; systemic, rectal

1.4

182.5

23712

106099

A10BA02

ATC

metformin; oral

1.5

182.2

8732

32993

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.1

181.6

2033

5088

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

3.0

181.1

995

1748

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

6.7

181.0

392

305

P19

ICPC

Drug abuse

5.4

180.9

470

452

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

5.7

180.8

448

409

R01AD58

ATC

fluticasone, combinations; nasal

1.5

180.8

8562

32267

F31

ICD-10 Finland

Bipolar affective disorder

4.6

180.7

560

641

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.5

180.3

7436

27240

WX308

NOMESCO Finland

Sacral anesthesy

17.2

180.2

234

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

6.5

180.1

401

323

NF1AA

NOMESCO Finland

Hip X-ray examination

1.9

180.0

2614

7211

R06.5

ICD-10 Finland

Mouth breathing

1.9

179.9

2933

8415

U05

ICPC

Urination problems other

2.3

179.8

1638

3754

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.8

179.4

1121

2124

A07AA02

ATC

nystatin; oral

2.3

179.3

1657

3822

F20.9

ICD-10 Finland

Schizophrenia, unspecified

3.2

179.2

878

1434

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.7

179.1

3669

11298

R03AK08

ATC

formoterol and beclometasone; inhalant

2.5

179.0

1407

3008

R60.9

ICD-10 Finland

Oedema, unspecified

2.2

178.7

1789

4274

F33.8

ICD-10 Finland

Other recurrent depressive disorders

6.1

178.2

421

364

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

4.7

177.9

539

604

AA400

NOMESCO Finland

Electroconvulsive therapy

6.5

177.9

395

317

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

3.4

177.8

818

1281

RJ190, ,

NOMESCO Finland

49.6

177.7

181

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

3.2

177.7

872

1426

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.4

177.6

1549

3480

L14

ICPC

Leg/thigh symptom/complaint

1.9

177.6

2565

7062

S21

ICPC

Skin texture symptom/complaint

1.6

177.5

4889

16313

C01CA24

ATC

epinephrine; parenteral

2.2

177.5

1873

4575

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.8

177.4

3161

9329

K05.30

ICD-10 Finland

Periodontitis complex

1.6

177.0

4867

16231

S06

ICPC

Rash localized

2.2

176.8

1856

4523

S97

ICPC

Chronic ulcer skin

2.2

176.7

1850

4504

GD1AA, ,

SPAT

1.6

176.3

5778

20106

A10AE06

ATC

insulin degludec; parenteral

2.8

176.2

1059

1962

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.5

175.8

758

1134

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.4

175.8

1482

3277

P18

ICPC

Medication abuse

7.7

175.5

344

234

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

11.7

174.9

267

119

Z00.5

ICD-10 Finland

Examination of potential donor of organ and tissue

57.0

174.9

175

RS221, ,

NOMESCO Finland

4.5

174.5

558

657

G04CA02

ATC

tamsulosin; oral

1.5

174.4

7433

27393

R33

ICD-10 Finland

Retention of urine

1.9

174.4

2499

6860

EBA10

NOMESCO Finland

Operative extraction of tooth

1.6

174.0

5066

17133

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

173.7

18612

80589

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

4.3

173.4

578

706

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

172.9

6224

22116

XF402

NOMESCO Finland

ECG with work load test

1.9

172.8

2510

6922

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

172.7

9687

37656

C10AA05

ATC

atorvastatin; oral

1.4

172.7

12899

52723

B01AF01

ATC

rivaroxaban; oral

1.7

172.4

3630

11260

S04

ICPC

Lump/swelling localized

1.7

171.7

3670

11433

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.0

171.5

2346

6333

SPAT1285

SPAT

Provision of consultation response

2.3

171.3

1628

3801

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.6

171.0

5710

19943

D10

ICPC

Vomiting

2.0

170.8

2205

5828

SXC05

NOMESCO Finland

Other oral or dental procedure

2.0

169.9

2359

6402

R01AD11

ATC

triamcinolone; nasal

1.9

169.8

2606

7323

N30.9

ICD-10 Finland

Cystitis, unspecified

2.0

169.7

2149

5639

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

4.0

169.6

617

811

R4190

NOMESCO Finland

Nutritional therapy

2.4

169.5

1368

2962

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.2

169.4

1802

4414

F22.0

ICD-10 Finland

Delusional disorder

4.0

169.1

615

808

P28

ICPC

Limited function/disability (P)

6.0

169.1

404

354

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.7

169.0

4288

13997

N76.0

ICD-10 Finland

Acute vaginitis

2.1

168.8

2072

5372

IGV01

NOMESCO Finland

Psychiatric network contact

4.7

168.5

504

558

ZX112

NOMESCO Finland

Subcutaneous

3.5

168.4

719

1068

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.3

168.4

780

1227

D07AC13

ATC

mometasone; topical

1.4

168.3

9422

36581

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.0

168.1

2292

6179

L11

ICPC

Wrist symptom/complaint

1.8

168.0

3003

8866

RJ410, ,

NOMESCO Finland

17.2

168.0

218

N05AX15

ATC

cariprazine; oral

10.0

167.6

278

145

Z01

ICPC

Poverty/financial problem

12.2

167.0

250

107

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.0

166.9

2166

5734

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

4.0

166.3

599

781

A02BC04

ATC

rabeprazole; oral

1.9

166.1

2538

7120

B01AA03

ATC

warfarin; systemic

1.6

166.0

5531

19296

-42

ICPC

Electrical tracing

5.4

165.3

434

422

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.5

165.1

1263

2663

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.7

165.0

3624

11371

K04.09

ICD-10 Finland

Pulpit UNS

2.2

164.9

1690

4075

C09CA06

ATC

candesartan; oral

1.5

164.6

7746

29078

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.3

164.5

1475

3355

XG466

NOMESCO Finland

Sleep oxymetry

3.0

164.4

919

1631

D02

ICPC

Abdominal pain epigastric

2.1

164.4

1889

4773

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.8

163.9

2842

8308

L04AX01

ATC

azathioprine; systemic

2.5

163.7

1297

2783

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.0

163.7

2161

5757

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.5

163.5

1258

2660

I50.9

ICD-10 Finland

Heart failure, unspecified

1.7

163.1

4082

13270

K29

ICPC

Cardiovascular sympt/complt other

2.5

162.9

1258

2665

C10AX09

ATC

ezetimibe; oral

1.6

162.8

4899

16682

XQ902

NOMESCO Finland

Other photography

5.3

162.7

435

431

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

5.8

162.7

401

364

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.5

162.6

1214

2529

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.8

162.2

3288

10079

S80.0

ICD-10 Finland

Contusion of knee

1.9

162.2

2555

7239

SDA03

NOMESCO Finland

Periodontal treatment

1.4

162.0

14354

60151

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.8

161.9

993

1861

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

8.5

161.3

295

181

ZY000

NOMESCO Finland

Hospital inpatient

4.1

161.2

562

713

SPAT1236

SPAT

Informing family of child’s disability

3.5

161.2

690

1027

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.7

161.2

3961

12812

C10AA07

ATC

rosuvastatin; oral

1.4

160.8

10390

41329

Z04.4

ICD-10 Finland

Examination and observation following alleged rape and seduction

222.7

160.4

214

H36.00

ICD-10 Finland

Diabetic background retinopathy

5.2

160.2

434

436

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.8

159.8

2996

8971

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

2.0

159.6

2056

5426

F43.01

ICD-10 Finland

Acute stress reaction moderate

3.6

159.6

653

940

Z72.2

ICD-10 Finland

Drug use

8.7

159.6

288

173

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.8

159.0

3153

9601

N04AA02

ATC

biperiden; systemic

3.3

158.6

734

1154

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

158.0

6984

25868

A11

ICPC

Chest pain NOS

1.9

157.8

2432

6839

C09CA01

ATC

losartan; oral

1.5

157.6

7828

29663

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.9

157.3

596

809

SPAT1106

SPAT

Acupuncture

7.4

157.2

315

221

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.4

157.1

1368

3069

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.9

156.7

887

1586

P16

ICPC

Acute alcohol abuse

3.5

156.6

683

1030

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

156.4

5163

17953

D09

ICPC

Nausea

2.2

156.4

1639

3988

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.8

156.3

2957

8876

R06AX22

ATC

ebastine; oral

1.5

156.1

5333

18691

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.8

156.0

2644

7669

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

2.3

156.0

1449

3347

U07

ICPC

Urine symptom/complaint other

1.9

155.6

2566

7378

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

4.4

154.8

504

603

K05.18

ICD-10 Finland

Chronic gingivitis

1.8

154.7

2649

7709

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.0

154.6

1995

5267

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.0

154.4

2030

5397

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

7.9

154.1

295

194

K08.3

ICD-10 Finland

Retained dental root

1.8

154.0

2612

7578

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

11.1

153.9

241

113

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

2.6

153.8

1062

2124

IEY01

NOMESCO Finland

Psychoeducation, individual

5.3

153.5

407

400

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

2.2

152.9

1508

3576

R07.0

ICD-10 Finland

Pain in throat

1.9

152.8

2489

7126

F03

ICPC

Eye discharge

1.9

152.5

2247

6220

RJ421, ,

NOMESCO Finland

15.1

152.4

208

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

7.1

152.2

315

231

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

3.2

152.1

754

1241

L04AD02

ATC

tacrolimus; systemic

5.8

152.0

373

337

ACC51

NOMESCO Finland

Release of median nerve

1.9

151.6

2192

6028

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.0

151.6

816

1415

B18.2

ICD-10 Finland

Chronic viral hepatitis C

4.7

151.3

458

513

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.4

151.0

1287

2858

R06.4

ICD-10 Finland

Hyperventilation

4.0

151.0

543

707

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

5.5

150.9

388

369

U29

ICPC

Urinary symptom/complaint other

2.8

150.9

941

1780

J01DA09

ATC

[U] cefadroxil

1.4

150.9

8726

33974

K99

ICPC

Cardiovascular disease other

2.9

150.8

857

1536

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

5.0

150.7

428

451

W19

ICD-10 Finland

Unspecified fall

1.7

150.7

3206

9958

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.6

149.8

4021

13292

UJD02

NOMESCO Finland

Gastroscopy

2.4

149.7

1301

2916

M54.8

ICD-10 Finland

Other dorsalgia

2.2

149.5

1481

3518

C10AC01

ATC

colestyramine; oral

3.0

149.3

819

1437

N05AE04

ATC

ziprasidone; systemic

6.8

149.3

319

244

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

4.4

149.1

477

562

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.2

148.7

1604

3949

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2579

5595

2.48

321.93

5.2

4.4

1.66

1.65

0.28

2471

5232

(3023520) Reticulocytes [#/volume] in Blood

4305

11658

2.02

319.86

3.0

2.5

71.57

68.70

e9/l

4.78

3512

8025

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

6667

20933

1.77

317.56

2.4

1.9

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

36905

173297

1.74

314.86

5.4

4.4

4.55

4.70

mmol/l

146.43

35064

163421

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

36710

172279

1.72

310.25

5.3

4.3

1.41

1.45

mmol/l

37.99

34849

161458

(3019225) pH of Specimen

5398

9985

3.06

307.65

5.1

3.4

7.37

7.34

16.93

4175

7043

(3021960) Folate [Moles/volume] in Serum or Plasma

13138

39815

2.03

307.65

1.8

1.6

19.66

19.63

nmol/l

0.07

11558

33983

(3012544) pH of Venous blood

5132

14565

1.94

307.65

5.3

3.3

7.37

7.38

1.98

3230

7336

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

23645

79896

2.19

307.65

7.9

5.9

10.66

12.10

umol/l

47.12

22660

75802

(3035941) MCH [Entitic mass]

40784

197227

2.38

307.65

31.3

17.8

30.27

30.25

1.84

40539

194869

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

31104

119070

2.28

307.65

5.3

3.5

11.39

11.11

mm/h

2.66

29658

111087

(3013650) Neutrophils [#/volume] in Blood by Automated count

25083

91649

2.01

307.65

11.9

8.6

4.11

4.19

e9/l

6.11

23077

76985

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

16890

46459

2.46

307.65

3.4

2.4

59.02

65.64

u/l

1.61

15948

42913

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

35593

160475

1.87

307.65

6.7

5.1

39.51

38.25

mmol/mol

111.17

33839

150705

(3013512) EKG study

15995

45408

2.32

307.65

3.8

3.2

0.72

0.03

102

(3019150) Specific gravity of Urine by Refractometry

11212

37345

1.75

307.65

4.8

3.2

1.28

1.11

kg/l

0.41

7835

22322

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

22768

72563

2.33

307.65

9.5

5.9

1.21

mmol/l

0.70

20679

60151

(3012516) Albumin [Mass/volume] in Urine

13311

47319

1.67

307.65

3.8

3.2

53.07

49.04

mg/l

0.95

9326

29834

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

5000

13485

2.05

307.65

2.7

2.0

0.21

g/l

1.19

4721

12550

(3019069) Monocytes/Leukocytes in Blood

20843

73875

1.90

307.65

8.0

5.6

8.72

8.80

3.66

19831

69230

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

11096

37832

1.70

307.65

2.9

2.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

2914

5291

2.99

307.65

4.0

2.2

—

(3021440) Promyelocytes/Leukocytes in Blood

5703

12785

2.52

307.65

5.4

3.9

0.11

0.14

1.15

1576

3194

(3021601) Nitrite [Presence] in Urine by Test strip

22510

89299

1.65

307.65

4.6

3.2

0.00

estimate

1.12

6443

19386

(3015235) Bicarbonate [Moles/volume] in Capillary blood

2397

4581

2.82

307.65

3.3

2.8

24.52

24.83

mmol/l

2.87

2354

4484

(3019977) pH of Arterial blood

5639

16562

1.88

307.65

8.6

7.8

7.41

7.42

3.79

3711

7853

(3023103) Potassium [Moles/volume] in Serum or Plasma

39053

173816

2.78

307.65

23.7

14.1

3.98

3.96

mmol/l

23.13

38533

169179

(3024354) Oxygen [Partial pressure] in Venous blood

4508

11856

2.09

307.65

4.5

2.7

4.67

4.53

kpa

3.62

4395

11535

(3017181) Myelocytes/Leukocytes in Blood

5969

13249

2.55

307.65

5.3

3.9

0.94

0.99

0.52

1838

3648

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

8483

23174

2.12

307.65

2.2

1.7

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

32229

129934

2.14

307.65

5.0

3.8

14.72

14.64

pmol/l

6.24

30356

118969

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

32291

123162

2.44

307.65

10.0

6.9

78.70

78.95

u/l

0.35

31184

116204

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

36277

163620

1.96

307.65

5.4

4.2

5.96

5.81

mmol/l

72.73

34180

151004

(3008152) Bicarbonate [Moles/volume] in Arterial blood

3481

8535

2.22

307.65

9.0

6.2

24.67

24.42

mmol/l

2.96

3402

8102

(3012095) Magnesium [Moles/volume] in Serum or Plasma

8052

24537

1.86

307.65

4.6

3.2

0.82

mmol/l

2.26

7667

23062

(3019309) Folate [Moles/volume] in Red Blood Cells

8164

21942

2.15

307.65

1.8

1258.52

1204.39

nmol/l

4.76

6428

16543

(3037467) Urinalysis macro (dipstick) panel - Urine

27785

113229

1.77

307.65

5.4

3.7

2.29

2.48

0.11

235

(40760892) CBC W Ordered Manual Differential panel - Blood

11847

39722

1.76

307.65

5.5

4.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

1441

1786

4.30

307.65

6.5

4.8

373.29

359.16

umol/l

2.33

1300

1536

(3009508) Creatinine [Moles/volume] in Urine

15658

52205

1.87

307.65

3.9

3.1

7.77

8.09

mmol/l

10.55

13829

44227

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2967

4166

3.90

307.65

2.4

1.7

—

(4198724) Urine methamphetamine measurement

698

532

6.91

307.65

2.8

1.8

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

14718

54453

1.61

307.65

4.3

2.8

32.80

34.15

u/l

1.10

14069

51288

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2146

3770

3.06

307.65

5.4

3.2

24.65

24.84

mmol/l

1.91

1996

3480

(3020779) Urea [Moles/volume] in Serum or Plasma

4949

12275

2.23

307.65

10.7

5.8

9.28

9.79

mmol/l

4.44

4782

11699

(3029937) Albumin [Presence] in Urine by Test strip

14857

48835

1.88

307.65

4.9

3.3

0.00

estimate

4.09

6201

17652

(3013115) Eosinophils [#/volume] in Blood

23787

82555

2.11

307.65

8.2

5.5

0.19

e9/l

0.35

21760

70553

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

13342

38777

2.14

307.65

3.8

2.8

1437.47

1447.33

ng/l

0.07

11507

32919

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

7927

21385

2.13

307.65

2.2

1.6

1.52

1.38

44.66

7178

18951

(40768797) Stomach Pathology biopsy report

6380

17552

2.04

307.65

1.3

1.2

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

19127

65890

1.91

307.65

8.6

5.8

1.21

mmol/l

0.22

17894

61049

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

37170

164542

2.26

307.65

18.3

12.2

84.43

ml/min/173m2

0.00

35245

148102

(3027801) Oxygen [Partial pressure] in Arterial blood

5713

16459

1.92

307.65

8.4

7.8

12.24

12.59

kpa

4.40

5542

15768

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

15030

42439

2.29

307.65

2.7

2.0

210.82

231.82

u/l

1.11

14451

39933

(3007164) IgA [Mass/volume] in Serum or Plasma

9665

30902

1.80

307.65

1.6

1.4

2.34

2.38

g/l

1.07

6678

20061

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

10337

32934

1.83

307.65

2.2

1.6

1.05

1.27

mg/l

10.83

7852

25548

(3020564) Creatinine [Moles/volume] in Serum or Plasma

40076

187730

2.55

307.65

25.5

15.3

79.43

76.41

umol/l

39.70

39768

185249

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

8670

27844

1.77

307.65

1.4

1.3

36.76

37.51

iu/ml

0.06

2457

8491

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

18085

56086

2.16

307.65

4.5

3.2

72.53

57.44

ng/l

0.49

13132

35836

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

20586

69003

2.05

307.65

2.8

2.2

75.45

75.67

nmol/l

0.47

19144

63045

(3006504) Eosinophils/Leukocytes in Blood

20752

73628

1.89

307.65

7.9

5.6

2.83

2.80

1.13

19725

68970

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

5338

14388

2.06

307.65

5.2

4.2

31.71

31.76

0.11

3701

9623

(3016502) Oxygen saturation in Arterial blood

5291

14555

2.01

307.65

8.6

8.2

95.51

95.54

0.11

5156

14020

(3024731) MCV [Entitic mean volume] in Red Blood Cells

40784

197226

2.38

307.65

31.4

17.9

90.91

90.62

29.20

40537

194866

(3026361) Erythrocytes [#/volume] in Blood

40790

197259

2.38

307.65

31.4

17.9

4.50

4.55

e12/l

86.76

40341

191239

(3002179) Metamyelocytes/Leukocytes in Blood

5695

12648

2.54

307.65

5.0

3.8

0.67

0.72

0.56

1812

3343

(3035350) Ketones [Presence] in Urine by Test strip

22606

90352

1.63

307.65

4.6

3.2

2.43

3.11

estimate

0.36

6607

19588

(3042936) Bacteria identified in Isolate by Culture

6901

20920

1.85

307.65

2.4

1.8

—

(3025159) Blasts/Leukocytes in Blood

5916

12820

2.62

307.65

5.9

4.0

0.27

0.24

0.14

1467

3103

(3026008) Bacteria identified in Urine by Culture

13542

44776

1.83

307.65

3.7

2.7

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

15457

57734

1.61

307.65

4.3

2.9

2.26

1.39

e6/l

—

(3001604) Monocytes [#/volume] in Blood

23141

79774

2.09

307.65

7.9

5.4

0.58

0.59

e9/l

3.72

21115

66583

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

40790

197234

2.38

307.65

32.0

18.3

40.63

41.62

11.17

40530

194769

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

11042

35762

1.81

307.65

1.4

1.3

1.36

1.75

u/ml

3.10

3815

10465

(3003458) Phosphate [Moles/volume] in Serum or Plasma

6973

18260

2.17

307.65

8.1

4.9

1.05

1.03

mmol/l

5.51

6581

16938

(3005719) IgG [Mass/volume] in Serum or Plasma

4158

10349

2.20

307.65

3.1

2.6

10.26

10.80

g/l

11.87

3923

9430

(3048689) Calprotectin [Mass/mass] in Stool

6783

19193

1.99

307.65

2.5

2.6

138.90

135.88

ug/g

0.21

5393

15427

(3002032) Base excess in Venous blood by calculation

4923

13903

1.95

307.65

5.5

3.3

1.91

1.71

mmol/l

3.19

4306

12233

(3031040) Bacteria [#/volume] in Urine by Automated count

27360

106903

1.90

307.65

5.7

3.8

1088.98

1471.00

e6/l

0.64

260

2156

(3032080) INR in Blood by Coagulation assay

20773

68064

2.13

307.65

15.8

12.7

1.23

1.24

inr

1.73

18316

55456

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

6078

13828

2.49

307.65

8.6

5.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

10439

32166

1.90

307.65

1.7

5327112.02

34157281.78

pmol/l

12.16

9199

26674

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

38589

173794

2.46

307.65

21.1

11.9

21.45

25.56

mg/l

107.02

33535

137686

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3530

6958

2.78

307.65

4.6

3.0

1.46

2.02

mmol/l

13.15

2596

5026

(3000963) Hemoglobin [Mass/volume] in Blood

40796

197329

2.38

307.65

31.7

18.0

135.35

136.96

g/l

82.85

40530

195048

(3037522) Nuclear Ab [Titer] in Serum

6837

20251

1.89

307.65

1.4

1.3

524.30

504.39

titre

0.35

1480

3743

(3036481) Cortisol [Moles/volume] in Serum or Plasma

5570

12508

2.51

307.65

2.4

2.3

362.25

387.45

nmol/l

13.47

5199

11769

(3019550) Sodium [Moles/volume] in Serum or Plasma

39012

173299

2.79

307.65

23.7

13.9

139.49

139.69

mmol/l

46.27

38534

169050

(3006315) Basophils [#/volume] in Blood

23206

79905

2.10

307.65

7.9

5.4

0.04

e9/l

1.03

21165

66640

(3020891) Body temperature

3177

6524

2.65

307.65

5.8

4.3

36.93

36.90

°c

4.87

3162

6447

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3777

9478

2.17

307.65

1.9

1.5

—

(3007461) Platelets [#/volume] in Blood

40779

197087

2.39

307.65

31.5

17.9

252.24

251.94

e9/l

0.39

40408

191815

(3021589) Normoblasts [#/volume] in Blood

20292

76255

1.72

307.65

13.6

10.3

0.00

e9/l

0.55

18124

60117

(3002030) Lymphocytes/Leukocytes in Blood

21056

77060

1.82

307.65

7.9

5.5

28.13

27.97

1.17

20263

72868

(3023368) Bacteria identified in Blood by Culture

12850

41945

1.84

307.65

4.7

4.1

—

(3022096) Basophils/Leukocytes in Blood

20691

73717

1.88

307.65

8.0

5.6

0.68

0.67

2.60

19689

68936

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

35514

162210

1.78

307.65

4.7

3.7

1.34

1.28

mmol/l

43.44

33499

150967

(3020682) Albumin/Creatinine [Ratio] in Urine

13491

48324

1.65

307.65

4.3

3.9

10.09

8.01

mg/mmol

4.30

9095

29539

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

36117

157847

2.16

307.65

6.2

4.4

1.85

1.89

mu/l

2.96

34342

146320

(3007853) Bacteria identified in Skin by Aerobe culture

6160

16924

2.04

307.65

2.0

1.6

—

(3045414) Leukocytes [Presence] in Urine

5642

10952

2.93

307.65

2.2

1.8

0.00

0.04

estimate

10.14

1796

2476

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

8248

25340

1.85

307.65

1.4

1.3

8.80

10.89

u/ml

2.30

3933

10355

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

12906

37821

2.10

307.65

2.6

2.1

2.90

2.77

mg/l

6.46

11487

32314

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

5050

9389

3.03

307.65

2.9

2.0

6.20

8.70

ug/l

8.34

4509

8283

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

5715

16471

1.92

307.65

8.4

7.8

5.12

5.08

kpa

1.70

5545

15789

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

28279

121952

1.59

307.65

4.4

2.7

49.64

44.81

u/l

12.52

27068

115399

(3018010) Neutrophils/Leukocytes in Blood

21119

74597

1.92

307.65

7.8

5.4

57.04

57.30

2.26

20356

71446

(3009261) Glucose [Presence] in Urine by Test strip

22744

91140

1.63

307.65

4.6

3.2

0.02

0.19

estimate

1.15

6254

18726

(3009343) pH of Capillary blood

4023

8024

2.77

307.65

4.7

3.1

7.41

7.42

8.77

3459

6582

(3004789) Transferrin [Mass/volume] in Serum or Plasma

7773

22677

1.95

307.65

3.1

2.2

2.38

2.33

g/l

10.37

7245

20682

(3018405) Lactate [Moles/volume] in Arterial blood

2289

4313

2.85

307.65

5.0

4.0

1.41

1.46

mmol/l

0.88

2253

4236

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

3054

6516

2.54

307.65

4.1

3.5

49.38

47.34

3.47

3014

6421

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

826

747

5.83

307.65

2.0

1.6

—

(3045716) Anion gap in Serum or Plasma by calculation

1311

952

7.34

307.65

2.7

3.2

9.84

11.48

mmol/l

22.51

1289

944

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

18117

69430

1.61

307.65

4.4

3.1

0.33

0.40

estimate

0.16

5158

16362

(3002582) Erythrocytes [#/volume] in Urine

14188

51765

1.63

307.65

4.2

2.9

80.52

100.55

e6/l

0.74

12073

37023

(3030981) Hyaline casts [#/volume] in Urine by Automated count

5020

10503

2.68

307.65

2.9

2.2

0.37

0.39

e6/l

0.17

4854

9817

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

18478

64454

1.85

307.65

2.3

1.9

97.29

94.92

pmol/l

8.52

10689

33950

(3013826) Glucose [Moles/volume] in Serum or Plasma

26463

92300

2.27

307.65

6.4

4.4

6.66

6.62

mmol/l

1.95

25421

86166

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

39644

186979

2.26

307.65

14.7

9.4

27.20

27.02

u/l

0.74

38921

181356

(3021447) Carbon dioxide [Partial pressure] in Venous blood

5416

14225

2.12

307.65

5.2

3.3

5.88

5.81

kpa

4.76

5281

13893

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

5533

16073

1.90

307.65

5.2

4.1

238.59

246.92

u/l

3.18

5217

15331

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

7026

20785

1.90

307.65

3.2

2.3

22.47

23.32

4.76

6575

19145

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

4232

8173

2.87

307.65

4.7

3.1

5.14

kpa

0.12

4063

7815

(3001122) Ferritin [Mass/volume] in Serum or Plasma

21406

80806

1.75

307.65

3.7

2.7

119.20

120.75

ug/l

0.35

20294

75775

(3000850) Epithelial cells [#/volume] in Urine

11121

34253

1.92

307.65

3.3

2.4

5.33

5.96

e6/l

3.98

10540

30565

(3024561) Albumin [Mass/volume] in Serum or Plasma

19563

67669

1.92

307.65

6.2

4.5

35.74

35.79

g/l

0.54

18565

63143

(3017732) Neutrophils [#/volume] in Blood

6914

16905

2.34

307.65

4.0

2.7

4.79

4.52

e9/l

1.22

6006

14974

(3022948) Iron [Moles/volume] in Serum or Plasma

8451

24297

2.00

307.65

3.1

2.2

13.23

13.49

umol/l

2.13

7953

22464

(44816559) Phosphatidylethanol [Mass/volume] in Blood

3195

6406

2.72

307.65

2.1

1.6

0.28

0.32

mg/l

2.07

1578

3215

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2804

3848

3.98

307.65

2.2

1.6

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

19970

76736

1.65

307.65

3.2

2.6

—

estimate

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

15436

52648

1.81

307.65

3.2

3.6

2.35

mmol/l

13.73

14232

48373

(3010813) Leukocytes [#/volume] in Blood

40793

197284

2.38

307.65

31.5

17.9

6.86

6.70

e9/l

28.19

40374

191232

(3045424) Erythrocytes [Presence] in Urine

3693

5354

3.82

307.65

2.3

1.8

0.19

0.05

estimate

0.45

1646

1867

(3019198) Lymphocytes [#/volume] in Blood

23423

82344

2.04

307.65

8.0

5.4

1.94

1.93

e9/l

0.41

21645

70954

(3017143) Hepatitis C virus Ab [Presence] in Serum

6392

19998

1.77

307.11

1.8

1.5

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

720

631

6.01

301.35

13.6

13.0

0.61

mmol/l

0.03

678

571

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

951

1114

4.51

299.45

1.6

1.3

—

(3003396) Base excess in Arterial blood by calculation

5478

16510

1.83

296.30

8.6

7.7

1.29

0.80

mmol/l

15.28

4538

13713

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

37194

175721

1.72

294.41

5.8

4.9

2.67

2.79

mmol/l

116.54

35283

164794

(3018095) Leukocytes [#/volume] in Urine

15485

60860

1.50

293.93

4.9

3.3

98.51

101.44

e6/l

0.13

12495

39833

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

961

1161

4.37

292.25

1.6

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

7059

23162

1.70

285.10

2.5

2.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

933

1130

4.36

282.89

1.6

1.3

—

(42870588) Differential panel, method unspecified - Blood

13541

52064

1.51

282.30

8.0

5.6

5.28

5.98

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1035

1374

3.98

281.35

1.7

1.6

382.77

393.49

mu/l

0.15

869

1131

(3026493) Urate [Moles/volume] in Serum or Plasma

11343

42146

1.54

275.35

3.2

2.4

339.48

343.37

umol/l

3.40

10180

37539

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3473

9197

2.04

271.70

4.7

3.5

95.59

87.18

ng/l

3.46

3031

7907

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

5615

17519

1.76

269.11

2.0

1.6

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

6751

22237

1.68

266.95

2.7

1.9

29.49

29.79

3.29

6564

21648

(3043409) Potassium [Moles/volume] in Arterial blood

1817

3619

2.68

266.73

5.8

4.2

3.86

3.90

mmol/l

2.81

1811

3590

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1687

3244

2.77

263.99

1.5

1.3

525.36

574.86

mg/l

0.71

1619

3122

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4680

13888

1.84

263.57

9.4

8.6

122.46

122.39

g/l

0.07

4612

13522

(3027945) Reticulocytes/Erythrocytes in Blood

5239

16127

1.78

262.13

3.2

2.4

1.84

1.72

12.96

4693

14383

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1545

2853

2.88

259.47

1.4

1.2

3.77

3.70

mmol/l

1.19

1470

2706

(3044889) 12 lead EKG panel

26441

117100

1.45

257.59

4.1

3.5

0.39

3346.43

0.79

165

(3028026) IgM [Mass/volume] in Serum or Plasma

3131

8135

2.08

256.84

1.9

1.23

1.31

g/l

1.46

2924

7492

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

869

1078

4.25

256.19

1.6

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

868

1077

4.25

255.83

1.6

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

869

1081

4.24

255.36

1.6

1.3

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

313

20.45

254.96

4.0

8.3

72.54

71.46

0.14

280

(3000494) Fungus identified in Specimen by Culture

5636

17920

1.73

251.70

1.7

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1714

3429

2.66

249.28

1.4

1.2

—

(3026782) Osmolality of Urine

8618

30663

1.57

248.70

3.5

2.5

503.01

547.28

mosm/kgh2o

61.32

7956

26633

(3023183) Ammonium ion [Moles/volume] in Plasma

1508

2814

2.85

248.59

3.2

2.3

31.69

34.85

umol/l

5.08

1393

2517

(3020630) Protein [Mass/volume] in Serum or Plasma

3822

10805

1.92

248.36

2.7

2.4

65.98

66.41

g/l

2.47

3528

9982

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1715

3445

2.65

247.51

1.4

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

3295

8866

2.01

245.96

1.4

1.2

228.10

260.56

u/ml

0.80

3065

8241

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2037

4494

2.42

244.02

2.4

2.2

426.98

681.37

ug/l

2.38

1917

4264

(3017354) Segmented neutrophils/Leukocytes in Blood

794

975

4.29

236.81

3.8

2.9

56.28

58.18

1.22

716

852

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

716

804

4.68

235.90

1.8

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

716

804

4.68

235.90

1.8

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

716

804

4.68

235.90

1.8

1.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

339

138

12.84

231.76

1.4

1.2

1.18

mmol/l

0.36

339

138

(3018418) pH of Serum or Plasma

11960

46295

1.47

230.39

5.1

3.7

7.39

7.40

18.78

9359

30715

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2223

5249

2.26

229.24

2.3

1.8

1.99

2.54

ug/l

1.10

1982

4674

(3027273) Bicarbonate [Moles/volume] in Venous blood

2466

6088

2.17

229.00

4.5

2.9

25.19

25.24

mmol/l

0.29

2398

5857

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1103

1814

3.21

223.05

1.4

1.3

25.35

26.22

u/l

0.31

914

1533

(3015736) pH of Urine

17173

71442

1.41

222.86

4.2

2.8

6.34

6.15

89.29

10439

38617

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3414

9637

1.91

221.65

2.5

2.3

19.09

20.76

au/ml

0.55

335

1264

(3037121) Protein [Mass/volume] in Urine

1805

3941

2.44

220.57

3.5

3.6

702.84

500.04

mg/l

0.59

832

2105

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

8244

29736

1.54

220.36

2.6

3.2

2.44

2.45

mmol/l

11.44

7562

26449

(3029634) Reagin Ab [Titer] in Serum by VDRL

1039

1669

3.29

217.67

1.9

1.7

7.56

2.77

titre

0.60

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1646

3468

2.52

216.18

1.5

1.4

283.96

269.24

ug/g

1.57

935

2020

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

5209

16886

1.68

214.19

2.1

1.7

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1484

3000

2.62

211.17

1.5

1.4

3909.69

1024.00

e6/l

0.63

1252

2271

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3170

8899

1.92

208.63

1.3

1.2

49.18

52.17

au/ml

0.30

173

665

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

3262

9279

1.89

206.39

3.3

3.6

4.48

4.56

pmol/l

3.93

2965

8466

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

719

917

4.12

205.01

22.5

18.4

1327.91

3038.81

nmol/l

0.52

694

890

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

753

1008

3.93

202.33

2.0

1.5

—

(3030467) Casts [#/volume] in Urine by Automated count

11532

45246

1.44

201.31

3.9

2.8

0.35

0.47

e6/l

5.05

9535

30803

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

690

873

4.15

198.62

17.1

13.4

758.06

1973.12

nmol/l

0.55

664

844

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1446

2982

2.57

197.88

1.4

23.18

36.95

e6/l

0.93

1162

2102

(3022145) Colonoscopy Study observation

5052

16648

1.65

193.81

1.4

—

(4024509) Urine culture

1997

4851

2.19

192.01

2.1

1.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

13008

52543

1.41

191.23

3.6

2.8

0.28

0.18

estimate

0.41

5173

15747

(46235355) HIV 1 and 2 tests - Meaningful Use set

9686

37119

1.46

189.09

2.2

1.9

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2150

5441

2.11

186.86

2.0

1.9

40.56

39.60

u/l

1.12

1951

4868

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

683

918

3.91

182.56

2.1

1.6

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2121

5413

2.09

180.29

1.3

1.2

0.94

0.65

u/ml

0.52

176

479

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1691

3953

2.27

177.55

1.9

1.6

0.23

0.24

g/l

4.57

1625

3800

(3014111) Lactate [Moles/volume] in Serum or Plasma

4160

13320

1.69

176.68

8.4

7.8

1.41

1.35

mmol/l

2.57

4069

13067

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

7473

27532

1.49

175.75

4.8

3.3

348.32

603.90

ng/l

6.08

5023

20982

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

463

452

5.36

175.66

1.9

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

463

452

5.36

175.66

1.9

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

463

452

5.36

175.66

1.9

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

463

452

5.36

175.66

1.9

1.7

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1722

4083

2.24

174.97

1.9

1.6

1.19

1.20

g/l

0.93

1652

3941

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

3544

10875

1.75

174.85

3.0

2.4

66.91

69.88

ml/min/173m2

3.70

1575

4748

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

841

1365

3.24

173.31

1.8

1.6

2617.78

5274.29

titre

0.45

(3044242) Glucose [Moles/volume] in Arterial blood

559

673

4.35

170.49

1.9

2.1

8.11

7.88

mmol/l

0.51

559

673

(3026250) Tacrolimus [Mass/volume] in Blood

413

369

5.86

169.94

44.1

38.4

7.54

7.41

ug/l

0.35

375

338

(3004809) Band form neutrophils/Leukocytes in Blood

1050

1977

2.80

169.85

4.0

2.9

1.52

1.60

0.24

965

1781

(3003129) Base excess in Capillary blood by calculation

764

1178

3.41

169.78

2.3

1.9

0.44

0.53

mmol/l

0.23

712

1140

(3007930) Methemoglobin/Hemoglobin.total in Blood

2040

5259

2.06

168.72

5.9

4.5

0.80

0.89

19.47

1942

4904

(3023420) DNA double strand Ab [Units/volume] in Serum

2127

5573

2.03

168.57

1.9

1.7

5.78

7.80

iu/ml

1.96

689

1104

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2528

7071

1.91

166.87

2.5

2.2

6606.76

6788.82

u/l

0.08

923

2867

(40758558) Short blood count panel - Blood

11445

46122

1.39

164.96

8.0

5.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

483

527

4.80

164.03

2.8

1.6

156.54

110.98

umol/l

1.81

247

250

(3020191) Ethanol [Moles/volume] in Serum or Plasma

735

1134

3.41

163.18

1.7

1.3

1.43

1.28

promille

1.37

530

875

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

896

1575

2.99

162.86

7.9

5.4

11.49

11.43

mg/l

0.11

838

1445

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1378

3058

2.38

162.06

1.4

1.2

29.96

43.45

u/ml

1.03

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4992

17127

1.58

160.54

3.3

2.4

7.86

9.41

umol/l

4.12

4308

14871

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1328

2939

2.39

157.05

1.7

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

8115

31037

1.44

155.28

1.9

1.7

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2854

8531

1.79

152.87

5.9

3.4

24.22

24.20

mmol/l

0.12

2821

8431

(3009214) Lutropin [Units/volume] in Serum or Plasma

1977

5227

2.01

152.61

1.5

1.3

9.67

9.03

u/l

1.20

1650

4185

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

510

627

4.26

151.85

3.2

2.2

212.68

239.26

e6/l

1.56

441

509

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1308

2920

2.37

151.79

1.3

1.2

15.67

17.64

u/ml

—

(3047181) Lactate [Moles/volume] in Blood

1620

3972

2.16

151.71

6.5

4.9

1.39

1.29

mmol/l

2.81

1497

3403

(4146454) Self-monitoring of blood glucose

499

604

4.33

151.27

2.9

2.0

—

(36304419) Bacteria [Presence] in Urine

10782

43554

1.38

150.34

3.7

2.8

1325.93

1.97

estimate

0.72

163

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1262

2798

2.38

148.60

9.1

3.8

858.46

3617.52

iu/ml

0.62

246

285

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1293

2910

2.35

147.40

1.7

1.3

19.24

23.37

u/ml

0.44

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1288

2895

2.35

147.24

1.5

1.2

260.09

247.15

u/ml

0.85

842

1861

(3028626) Oxygen [Partial pressure] in Capillary blood

1628

4053

2.13

146.78

4.7

3.1

8.53

8.27

kpa

6.54

1596

3950

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1809

4695

2.04

146.62

1.4

1.2

—

(3025941) Bacteria identified in Stool by Culture

2858

8664

1.76

145.84

1.3

1.2

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3137

9771

1.72

145.77

10.5

9.9

1.52

1.30

20.51

3124

9714

(3003181) Sodium [Moles/volume] in Urine

1096

2295

2.52

145.17

1.5

1.4

61.66

61.64

mmol/l

0.00

858

1791

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2586

7625

1.81

144.54

1.9

1.6

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

2920

8968

1.74

142.40

4.4

2.8

128.77

131.23

g/l

6.18

2834

8715

(3014007) Fractional oxyhemoglobin in Arterial blood

3132

9825

1.71

141.74

10.6

10.1

93.80

93.81

0.02

3124

9793

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

490

627

4.09

139.17

3.0

2.1

492.73

515.31

e6/l

0.39

409

471

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2027

5616

1.92

136.90

1.6

1.5

10.87

12.92

iu/ml

0.31

141

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3020

9482

1.70

136.02

10.8

10.2

0.69

0.63

13.29

3010

9436

(3008037) Lactate [Moles/volume] in Venous blood

1305

3061

2.25

135.53

2.4

2.7

1.53

1.65

mmol/l

3.21

1271

2977

(3011412) CD3 cells [#/volume] in Blood

655

1070

3.21

133.63

3.0

2.1

1234.03

1119.77

e6/l

2.00

577

945

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2564

7720

1.77

133.48

4.5

2.6

1.45

1.27

10.45

2556

7684

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

588

895

3.44

133.09

2.2

2.3

20.17

18.87

nmol/l

1.79

557

860

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2113

6003

1.87

132.35

1.8

1.6

1.52

g/l

0.10

1813

5112

(3011397) Hemoglobin [Presence] in Urine by Test strip

9401

37825

1.37

130.96

4.8

3.1

0.65

0.26

1.13

401

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1490

3750

2.10

130.53

1.3

1.2

27.29

39.34

u/ml

0.84

213

(3048929) Epstein Barr virus Ab [Presence] in Serum

1981

5539

1.90

130.11

1.4

1.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

441

549

4.20

129.44

2.6

2.5

146.19

144.40

nmol/l

0.09

401

452

(3000991) Gas panel - Venous blood

3942

13431

1.58

128.66

10.3

8.6

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

998

2123

2.47

127.98

4.1

2.1

866.74

3579.75

u/ml

1.90

114

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1641

4340

2.00

126.16

3.1

2.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1053

2318

2.39

125.75

1.3

1.2

205.45

85.14

titre

1.00

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1045

2294

2.40

125.54

1.3

1.2

297.84

324.78

titre

0.13

183

(3004616) Nuclear Ab [Presence] in Serum

711

1276

2.92

124.81

1.3

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1193

2789

2.25

124.77

1.3

1.2

4.24

6.57

u/ml

0.44

181

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

808

1562

2.72

124.55

2.5

2.4

22.47

28.43

iu/ml

0.70

118

(3023511) Choriogonadotropin [Units/volume] in Urine

1311

3193

2.17

124.50

1.5

1.2

—

(3042517) Benzodiazepines panel - Urine

215

122

9.19

123.51

2.8

3.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

358

386

4.85

123.17

33.8

25.7

119.27

126.93

ug/l

0.62

284

335

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1400

3521

2.10

122.78

1.3

1.2

2.66

10.07

u/ml

2.32

141

292

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1391

3514

2.09

120.60

1.3

1.2

7.45

8.69

u/ml

0.25

213

447

(3017446) Testosterone [Moles/volume] in Serum or Plasma

4558

16275

1.51

120.10

2.6

2.1

12.71

13.40

nmol/l

6.14

4152

14997

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

256

199

6.71

118.38

1.9

2.0

15.40

16.80

umol/l

0.78

256

199

(40757494) Bilirubin.total [Moles/volume] in Blood

419

542

4.04

117.50

2.3

2.0

32.95

51.12

umol/l

0.78

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3916

13605

1.54

116.78

3.9

3.8

1.23

1.22

mmol/l

3.86

3664

11391

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

529

821

3.37

116.48

1.2

75.63

61.57

u/ml

0.33

(3044290) Cell count panel - Cerebral spinal fluid

1212

2948

2.17

115.40

1.4

1.3

—

(3017569) Oxygen content in Arterial blood

487

719

3.54

115.07

2.0

2.4

16.26

16.00

0.72

487

719

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1352

3448

2.07

114.34

2.1

2.0

12.10

10.81

mg/l

2.09

1260

3280

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1152

2755

2.20

114.22

1.7

1.3

146.39

146.67

au/ml

0.02

302

821

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

519

809

3.36

113.56

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1148

2752

2.20

113.17

1.7

1.5

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3094

10257

1.61

112.38

3.8

2.6

184.66

209.89

ng/l

2.30

2828

9339

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

523

827

3.31

112.06

1.2

—

(36660697) Celiac disease serology panel - Serum

3485

11924

1.56

110.84

1.2

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

688

1299

2.78

110.65

1.1

38.48

63.22

au/ml

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1692

4743

1.89

109.97

1.7

1.6

29.05

2.32

iu/ml

1.06

312

858

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

226

166

7.10

109.17

2.4

1.9

1.18

1.19

mmol/l

0.40

213

155

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

592

1040

2.98

107.69

1.2

48.35

45.53

u/ml

0.07

(3038026) Centromere Ab [Units/volume] in Serum

466

702

3.47

107.09

1.2

70.55

44.50

u/ml

0.67

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

689

1331

2.71

106.35

1.4

1.3

1.64

1.43

nmol/l

3.71

636

1210

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

668

1273

2.75

105.68

2.1

1.7

26.75

30.20

mg/l

0.70

247

491

(3014271) Vancomycin [Susceptibility]

341

406

4.39

105.44

3.3

2.7

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

558

960

3.04

105.02

3.4

2.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

944

2147

2.31

104.97

1.6

1.5

0.67

0.83

g/l

5.07

790

1542

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1352

3567

2.00

104.41

1.9

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1173

2948

2.10

102.92

3.0

4.2

539.92

1190.49

u/ml

1.44

1044

2690

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

753

1552

2.55

102.82

1.2

1.1

5.19

20.94

u/ml

1.73

(3034770) Mitochondria Ab [Titer] in Serum

1445

3926

1.94

102.80

1.2

594.12

1121.27

titre

2.31

102

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

431

633

3.56

102.62

3.1

2.2

0.70

0.65

e9/l

0.79

417

596

(3026389) Candida sp identified in Specimen by Organism specific culture

855

1881

2.39

102.18

1.4

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

4037

14509

1.49

102.03

3.9

4.6

20.11

34.91

ug/l

2.05

3269

11669

(3007566) Smooth muscle Ab [Titer] in Serum

1467

4023

1.92

101.61

1.3

1.2

92.26

129.10

titre

1.48

168

435

(3049717) Cytology report of Urine Cyto stain

1753

5118

1.81

100.31

2.7

—

(3042733) HLA Ab [Presence] in Serum

293

318

4.81

100.20

4.8

5.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

541

942

3.01

99.88

1.1

278.61

273.16

mg/l

0.11

495

820

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1352

3643

1.96

98.44

2.0

1.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

551

981

2.94

98.07

1.3

1.2

2.02

2.17

mmol/l

1.66

517

911

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1662

4813

1.82

97.56

2.3

2.2

7.27

7.37

g/l

1.58

1499

4424

(3013139) Helicobacter pylori Ag [Presence] in Stool

2916

9854

1.57

97.28

1.3

1.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1658

4805

1.82

97.09

2.3

2.2

4.28

4.19

g/l

3.04

1497

4425

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1599

4588

1.84

96.62

2.4

2.2

2.65

2.98

g/l

27.96

1436

4202

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1654

4801

1.82

96.36

2.3

2.2

3.50

3.86

g/l

11.91

1496

4418

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

550

989

2.91

96.28

1.2

1.1

44.19

47.61

mg/l

0.35

492

803

(44806118) Parainfluenza type 4 nucleic acid detection

727

1524

2.50

96.00

1.8

1.3

—

(44790049) Parainfluenza type 3 nucleic acid detection

727

1525

2.50

95.87

1.8

1.3

—

(44790048) Parainfluenza type 2 nucleic acid detection

727

1526

2.50

95.75

1.8

1.3

—

(44790047) Parainfluenza type 1 nucleic acid detection

727

1528

2.49

95.50

1.8

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3848

13875

1.48

95.34

2.5

1.8

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

3081

10616

1.55

94.35

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

311

380

4.27

93.41

1.5

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

623

1224

2.67

93.24

1.1

1.0

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

311

381

4.26

93.13

1.5

1.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

400

598

3.49

92.96

1.1

4.41

9.51

nmol/l

0.93

136

(3021901) Oxygen saturation in Capillary blood

1263

3390

1.96

92.93

3.4

2.9

90.80

89.96

4.36

1238

3299

(3027923) C peptide [Moles/volume] in Serum or Plasma

391

577

3.54

92.53

1.6

1.29

1.26

nmol/l

0.12

289

477

(3021387) Prolactin [Units/volume] in Serum or Plasma

2141

6778

1.67

92.46

1.7

1.6

333.14

286.32

mu/l

5.55

2005

6042

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1062

2679

2.08

92.25

1.7

1.6

—

(3024932) HLA-DR beta [Type]

270

294

4.79

92.06

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

991

2439

2.14

91.59

1.1

—

(21494755) Public health laboratory ask at order entry panel

3153

23559

0.67

91.41

1.3

—

(3024471) HLA-A [Type]

274

305

4.69

91.28

1.0

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

642

1300

2.59

90.76

1.5

1.3

2.87

3.00

g/l

0.99

532

801

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

397

603

3.44

90.24

1.5

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2531

8413

1.60

90.24

1.1

1.0

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

641

1301

2.58

90.21

1.5

1.3

6.38

6.92

g/l

2.77

532

801

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

301

369

4.26

90.08

2.5

2.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

640

1300

2.58

89.93

1.5

1.3

0.36

0.42

g/l

3.14

532

798

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

3205

11269

1.51

89.31

2.2

1.7

—

(3020961) Endomysium IgA Ab [Titer] in Serum

2330

7608

1.62

89.26

1.2

1.1

235.38

228.00

titre

0.04

247

(3000034) Microalbumin [Mass/volume] in Urine

488

855

2.98

89.22

3.3

2.7

71.20

45.99

mg/l

0.79

362

592

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

2018

6347

1.68

89.22

2.1

1.7

39.55

40.14

nmol/l

0.49

1961

6272

(1175426) CD3 cells/Lymphocytes in Blood

508

912

2.91

89.20

2.7

1.9

72.31

72.54

0.10

487

884

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

392

596

3.44

88.99

1.5

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

5501

21480

1.38

87.61

2.0

1.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

3301

11762

1.49

86.23

1.2

115.13

149.02

u/ml

4.17

1197

4670

(3020717) Zinc [Moles/volume] in Serum or Plasma

399

630

3.31

85.78

1.7

1.3

22.43

26.96

umol/l

1.70

363

571

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

485

871

2.91

85.13

2.6

1.8

14.67

15.51

0.74

472

853

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

12711

55897

1.26

84.73

5.0

4.9

2.90

3.09

ug/l

0.24

11648

50700

(4062490) Immunoglobulin typing, IgG

622

1287

2.53

84.32

1.5

1.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1470

4297

1.80

83.60

3.4

3.2

45.23

44.19

mg/l

0.04

1343

3320

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

271

324

4.36

83.51

2.4

1.9

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

273

329

4.33

83.37

2.4

1.9

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1472

4314

1.80

83.01

3.4

3.2

50.76

60.11

mg/l

0.57

1346

3337

(3016244) Insulin [Units/volume] in Serum or Plasma

438

751

3.05

82.97

3.3

3.0

26.41

27.22

mu/l

0.15

410

720

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

270

324

4.35

82.86

2.4

1.9

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

346

511

3.53

81.85

1.4

1.6

9.21

7.88

ug/l

0.45

324

449

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1564

4690

1.76

81.72

2.1

1.8

197.52

207.52

pmol/l

2.62

1478

4497

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1134

3068

1.94

81.53

4.3

3.0

9.33

9.02

pmol/l

0.25

1134

3063

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1320

3772

1.84

80.64

1.2

1.1

3.63

3.95

0.67

129

703

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

491

918

2.80

80.43

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

711

1605

2.32

80.39

1.1

2.31

2.02

iu/ml

0.19

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

476

882

2.82

79.22

2.8

1.9

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

620

1325

2.45

78.77

1.4

1.5

—

(3034988) Calcium [Moles/volume] in Capillary blood

199

188

5.51

78.09

2.2

2.0

1.18

1.19

mmol/l

0.75

187

174

(3000475) Leukocytes [#/volume] in Synovial fluid

1186

3314

1.88

77.57

1.8

1.6

15247.14

13716.74

e6/l

0.41

911

2250

(3014765) Yersinia sp identified in Stool by Organism specific culture

1292

3716

1.83

77.33

1.2

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

759

1794

2.22

77.31

1.3

0.17

0.30

nmol/l

1.15

120

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

890

2245

2.08

77.31

1.4

1.3

8.24

12.73

u/ml

1.04

(42529406) Shigella sp [Presence] in Stool by Culture

1292

3721

1.83

77.00

1.2

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1282

3711

1.82

75.17

1.2

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

982

2605

1.98

74.60

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

217

235

4.81

74.51

3.4

2.9

1.95

2.04

ratio

0.23

204

215

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

105

13.66

74.08

4.6

2.2

2.19

2.23

mg/l

0.05

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

527

1078

2.56

73.12

1.3

1.2

109.86

112.60

pmol/l

0.45

527

1078

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

408

731

2.92

71.97

1.8

1.4

2219276.62

1694031.29

iu/ml

0.29

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

650

1487

2.29

71.38

1.3

—

nmol/l

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

423

778

2.84

71.36

1.1

1.3

0.63

0.68

ratio

0.57

298

368

(40761536) Microorganisms panel - Urine sediment

2359

17830

0.67

71.23

4.7

3.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

861

2213

2.04

71.23

1.9

2.0

4.88

5.38

mmol/24h

3.53

782

2026

(3020876) Protein [Mass/time] in 24 hour Urine

656

1518

2.26

70.20

2.6

1.45

1.30

g/24h

0.59

408

955

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1536

4783

1.69

70.20

1.8

1.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

3649

25474

0.72

70.14

1.9

3.58

3.53

ratio

1.34

2755

19347

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1219

3551

1.80

70.02

1.5

1.4

12.63

11.25

iu/ml

0.11

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

388

691

2.93

69.16

1.1

1.14

u/l

0.00

149

302

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1099

3119

1.85

68.54

2.4

122.21

112.86

ug/min

0.24

748

1853

(3010503) CD19 cells [#/volume] in Blood

395

717

2.88

68.18

3.1

2.2

427.38

183.85

e6/l

0.60

384

701

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2477

8716

1.50

68.13

10.3

24.20

24.29

mmol/l

0.59

2409

8524

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

247

325

3.96

68.04

2.5

1.4

30018.78

3881.03

u/ml

0.67

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

764

1911

2.09

67.82

1.1

1.50

1.51

g/l

0.22

700

1770

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1519

4762

1.68

67.71

3.7

2.3

3.47

3.69

g/l

6.48

1453

4565

(3006245) CD3-CD19+ cells/cells in Blood

284

419

3.53

67.37

2.9

2.0

10.53

9.72

0.34

265

396

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1531

4821

1.67

67.12

5.9

2.8

1.54

1.46

mg/l

3.17

1455

4400

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1285

3854

1.75

67.00

3.3

3.1

3.68

7.39

ratio

0.47

927

1752

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

484

992

2.55

66.94

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

369

658

2.93

65.66

1.4

5.79

5.93

u/l

0.07

322

570

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

264

377

3.65

65.48

2.8

1.7

28.69

29.22

0.19

252

360

(3022621) pH of Urine by Test strip

3226

12068

1.42

64.70

2.8

2.3

6.07

6.13

3.14

2078

7814

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1291

3917

1.73

64.68

1.5

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1750

5767

1.60

64.19

1.3

198.14

227.22

miu/ml

2.60

723

2821

(21494815) CD4 cells/Lymphocytes in Specimen

495

1050

2.46

63.94

2.8

2.0

40.01

38.13

1.58

485

1036

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

779

2021

2.02

62.89

1.3

1.2

—

14.43

—

(3008295) Osmolality of Serum or Plasma

617

1465

2.20

62.24

1.5

1.4

280.63

278.62

mosm/kgh2o

1.08

488

1135

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

711

1789

2.08

62.20

1.3

0.59

3.19

nmol/l

1.28

690

1718

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

643

1554

2.17

62.18

1.3

0.18

0.21

nmol/l

1.39

510

1188

(3044927) Protein electrophoresis panel - Urine

446

911

2.56

62.13

1.2

1.1

—

(3036489) Thrombin time

1747

5805

1.59

61.89

2.9

1.9

20.69

20.92

0.68

1493

5121

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2084

7212

1.53

61.81

1.1

11.59

4.67

u/ml

0.35

(3014148) Varicella zoster virus Ab [Titer] in Serum

817

2190

1.95

60.31

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

225

306

3.83

59.53

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

225

306

3.83

59.53

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

225

306

3.83

59.53

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

225

306

3.83

59.53

1.2

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

299

498

3.13

59.45

2.2

1.5

1.88

2.00

umol/l

1.32

268

444

(3007916) DNA double strand Ab [Titer] in Serum

131

105

6.49

59.33

1.5

1.2

109.00

35.59

titre

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1433

4580

1.65

59.32

4.2

2.9

0.34

0.35

iu/ml

0.68

869

2387

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

343

625

2.86

58.90

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

28.59

58.85

1.0

0.04

0.15

u/ml

0.42

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

376

724

2.71

58.57

2.9

3.8

131.47

179.44

nmol/l

0.65

366

715

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1032

3019

1.79

58.46

1.3

1.2

29.83

48.92

u/ml

3.31

280

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1623

5372

1.59

58.40

1.6

1.7

14.56

16.23

u/ml

0.46

315

1708

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

464

999

2.43

58.17

1.1

288.95

284.96

mg/l

0.47

426

920

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1340

4230

1.66

58.15

1.9

2.0

10.95

8.20

iu/l

0.15

554

1783

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

2715

19292

0.71

57.27

1.6

3.46

3.51

mmol/l

1.53

1840

12967

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

320

570

2.93

57.12

3.1

2.4

39.55

39.41

0.04

226

283

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

384

760

2.64

56.87

2.8

1.7

97.13

97.40

0.05

365

712

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

582

1411

2.16

55.90

1.3

1.2

35.17

26.18

nmol/l

0.50

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

358

690

2.71

55.70

1.0

271.52

338.13

ng/l

3.97

250

549

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

359

694

2.70

55.55

1.0

35.25

41.92

ng/l

2.28

250

546

(3037756) Immunofixation for Serum or Plasma

892

2538

1.84

55.20

1.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2339

8482

1.46

55.14

12.2

9.6

16.17

16.23

0.33

2276

8151

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

358

694

2.69

55.12

1.0

844.12

728.69

ng/l

3.17

243

525

(3048879) Bone marrow aspiration report

172

201

4.46

54.56

2.4

1.6

2.00

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

340

650

2.73

53.71

1.2

1.3

64.89

67.38

0.13

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

253

406

3.25

53.31

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

320

595

2.80

53.12

1.9

1.8

148.34

151.22

0.21

306

566

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

10075

45020

1.21

51.87

4.1

21.61

21.99

1.51

4673

20694

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

881

2553

1.81

51.47

2.0

1.5

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

397

842

2.46

51.40

1.4

1.2

5.25

5.63

umol/l

0.94

351

760

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

336

654

2.68

51.39

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

2263

8280

1.44

50.82

1.4

—

(3008898) HLA-B27 [Presence]

1683

5801

1.53

50.70

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

798

2254

1.85

50.54

1.3

34.14

27.85

u/l

0.71

697

1934

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1074

3320

1.70

50.35

1.6

1.3

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

1447

4828

1.57

50.29

2.1

1.8

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1325

4328

1.61

50.29

2.3

2.4

0.79

0.80

g/l

0.01

1133

3674

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1407

4671

1.58

49.95

1.5

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

2499

9344

1.41

49.82

1.5

1.3

23.70

26.40

iu/l

3.76

2202

7859

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

136

142

4.98

48.65

1.8

1.3

516928.24

15662.50

u/ml

0.47

(3010144) Erythrocytes [#/volume] in Synovial fluid

506

1227

2.15

48.64

1.5

1.3

166034.57

95294.13

e6/l

1.24

357

813

(3000093) Morphology [Interpretation] in Blood Narrative

496

1193

2.17

48.63

1.2

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

543

1356

2.09

48.52

3.2

3.5

7.68

13.39

nmol/l

0.44

527

1320

(3028433) Virus identified in Specimen by Culture

207

309

3.49

48.48

1.3

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

167

213

4.08

47.95

1.2

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

434

993

2.28

47.80

1.8

1.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

260

456

2.97

47.71

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

211

323

3.40

47.70

3.0

1.7

0.21

1.54

e9/l

0.75

101

131

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

295

560

2.75

47.27

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

437

1009

2.26

47.16

1.3

1.2

75.82

80.63

0.45

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1296

4293

1.58

46.43

2.2

9.57

10.39

g/l

9.05

1120

3879

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

221

357

3.22

46.18

1.2

109.68

110.30

0.10

201

321

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

229

385

3.10

45.02

1.2

0.30

0.31

g/l

0.22

189

292

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

924

2832

1.71

44.69

3.1

1.6

1.00

0.85

nmol/l

5.46

787

2505

(4195642) Thrombophilia screening test

766

2227

1.80

44.33

1.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

227

384

3.08

44.20

1.4

14.65

14.92

pmol/l

0.16

181

333

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

649

1792

1.89

44.07

1.3

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1451

4992

1.53

44.05

3.4

2.0

93.75

92.69

0.92

1396

4798

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

193

294

3.42

43.98

2.3

1.8

40.43

41.03

g/l

0.56

193

294

(3023419) Bacteria identified in Sputum by Culture

616

1674

1.92

43.83

2.9

2.2

—

(3011985) Renin [Units/volume] in Plasma

719

2059

1.83

43.68

1.6

1.5

65.61

68.18

mu/l

0.10

653

1851

(3037692) Legionella sp identified in Specimen by Organism specific culture

208

336

3.22

43.50

1.6

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

287

563

2.66

43.36

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

6244

27006

1.23

43.15

3.4

2.7

1.03

1.30

e6/l

1.23

3854

12068

(21494434) Karyotype in Bone marrow

404

938

2.25

43.10

1.3

1.1

—

(3016038) Potassium [Moles/volume] in Urine

375

844

2.32

42.91

1.3

1.2

33.49

34.82

mmol/l

0.45

330

746

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

208

340

3.19

42.74

1.2

67.16

67.33

ug/l

0.01

208

340

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

267

513

2.71

41.93

2.3

1.4

28.25

29.06

umol/l

0.53

245

468

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

886

2736

1.70

41.73

1.6

1.3

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

330

710

2.42

41.60

1.2

1.1

24.97

22.40

u/l

0.26

310

615

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

259

493

2.74

41.37

1.1

328.20

347.14

ng/l

0.03

149

(3007463) Buprenorphine [Presence] in Urine

8.23

41.03

5.3

12.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

904

2831

1.67

40.45

1.5

1.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1319

4531

1.53

40.31

3.6

2.2

179.93

191.64

4.85

1255

4322

(3017817) Protein [Mass] in Urine collected for unspecified duration

439

1091

2.10

39.81

2.9

2.4

1037.73

1116.50

0.34

429

1076

(40768446) Kidney Pathology biopsy report

263

516

2.66

39.77

2.0

1.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

464

1179

2.05

39.75

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

331

729

2.37

39.74

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

328

720

2.37

39.66

1.2

1.1

82.12

82.03

u/l

0.01

312

618

(40757373) Influenza virus identified in Isolate

150

205

3.81

39.63

1.6

1.4

—

(3039000) Anion gap in Blood by calculation

877

2742

1.67

39.48

9.3

5.8

11.33

11.36

mmol/l

0.07

808

2426

(3018572) Chloride [Moles/volume] in Blood

877

2743

1.67

39.43

9.3

5.8

104.91

104.96

mmol/l

0.10

808

2427

(3047007) Chlamydophila sp Ab [Presence] in Serum

742

2217

1.75

39.26

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

406

986

2.15

39.00

1.1

—

0.40

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

316

689

2.39

38.78

1.9

1.6

3.11

3.01

u/field

0.04

159

553

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

228

420

2.83

38.63

1.8

1.9

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

406

990

2.14

38.62

1.1

—

0.22

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

753

2276

1.73

38.30

1.2

1.1

114.69

117.05

1.09

702

2056

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

236

446

2.76

38.23

1.1

6.78

8.09

u/ml

0.24

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

666

1944

1.79

38.11

1.4

317.37

293.77

pmol/l

0.87

579

1680

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

234

442

2.76

37.95

1.2

1.3

—

(3006576) Bicarbonate [Moles/volume] in Blood

231

435

2.77

37.67

6.4

5.5

25.03

24.98

mmol/l

0.05

217

381

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

236

451

2.73

37.49

2.9

27.79

28.27

umol/l

0.22

169

346

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

103

106

5.05

37.48

1.5

1.3

45.60

54.43

0.77

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

176

283

3.24

37.15

1.2

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

353

826

2.23

37.07

1.5

21.48

26.31

u/ml

0.92

163

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

776

2389

1.70

37.00

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

301

659

2.38

36.65

1.4

1.6

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

226

431

2.73

36.06

1.1

1.2

107.38

105.23

0.27

208

393

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

274

579

2.47

35.93

2.8

2.4

54.88

51.39

umol/l

0.88

239

500

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

797

2494

1.67

35.80

1.3

1.2

3.91

3.53

u/ml

0.22

311

959

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

687

2064

1.74

35.72

1.1

2.64

2.71

0.07

425

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

30861

153333

1.16

35.61

23.2

15.0

13.64

13.50

63.03

30647

150618

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

177

294

3.13

35.58

1.2

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

755

2342

1.69

35.04

1.3

1.2

4.02

3.80

u/ml

0.14

355

1109

(3023410) Appearance of Cerebral spinal fluid

525

1460

1.88

35.01

1.8

1.5

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

229

448

2.66

34.89

1.1

1.3

12.86

22.60

1.11

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

122

157

4.04

34.80

1.7

1.2

81.33

100.78

ng/l

0.25

106

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

579

1667

1.81

34.68

1.1

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1201

9044

0.68

34.66

1.1

0.64

0.63

ratio

0.29

110

1054

(40768443) Skin Pathology biopsy report

1804

6790

1.40

34.43

1.2

—

(3033099) Centromere Ab [Titer] in Serum

148

223

3.45

34.38

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

723

2230

1.69

34.27

1.5

1.3

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

295

662

2.32

34.10

1.3

1.2

56.67

112.33

titre

0.70

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

12.37

33.86

1.9

1.7

196.68

190.63

nmol/l

0.04

(3006571) Granulocytes/Leukocytes in Synovial fluid

606

1785

1.77

33.71

1.5

59.72

56.84

0.90

378

1104

(21494890) Protein electrophoresis panel - 24 hour Urine

463

1254

1.93

33.40

2.0

1.9

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

615

1825

1.76

33.38

1.8

1.9

27.88

27.80

ug/l

0.01

599

1801

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1732

6510

1.40

33.31

1.8

1.6

5.53

3.93

mg/l

3.99

1421

4490

(3027456) Digoxin [Moles/volume] in Serum or Plasma

778

2467

1.65

33.27

3.2

0.82

0.81

nmol/l

0.28

606

2029

(3032057) Clostridioides difficile [Presence] in Stool

119

157

3.94

32.95

1.9

1.8

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

115

148

4.04

32.83

1.2

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1159

4048

1.50

32.81

1.1

5.30

4.78

eliau/ml

0.16

133

676

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

301

695

2.26

32.67

1.3

1.2

235.29

650.98

titre

1.52

(4015189) Microbial culture of sputum

141

213

3.44

32.66

2.8

2.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

214

419

2.66

32.60

1.1

1.2

91.79

90.52

0.14

111

200

(3047352) Trisomy 18 risk [Likelihood] in Fetus

661

5557

0.61

32.23

1.5

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

216

429

2.62

32.05

1.1

89.19

91.40

0.36

111

201

(3012920) Ethanol [Mass/volume] in Serum or Plasma

17.75

32.04

1.7

1.1

2.04

1.48

g/l

0.86

(3043238) Trisomy 21 risk [Likelihood] in Fetus

680

5662

0.62

31.82

1.5

1.6

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

107

134

4.15

31.57

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

785

2532

1.62

31.44

1.2

0.63

1.29

1.91

154

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

10.19

31.34

3.5

3.3

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

10.19

31.34

4.1

5.0

—

(3017509) Phencyclidine [Presence] in Urine

132

196

3.50

31.34

2.7

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

296

692

2.23

31.25

3.6

—

(3005033) Fetal Nuchal fold Thickness US

652

5458

0.61

31.22

1.5

1.26

0.10

454

3969

(4268621) Lupus anticoagulant assay

567

1677

1.76

31.16

2.3

—

(3024928) Oxygen saturation in Venous blood

1062

3682

1.51

31.14

5.0

2.7

65.27

61.74

5.59

1029

3576

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

107

136

4.09

31.03

2.1

1.7

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

371

954

2.03

30.94

1.2

1.1

1.26

3.30

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

100

121

4.30

30.72

2.1

1.9

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

237

505

2.44

30.64

1.4

1.5

484.40

863.36

mu/l

0.99

224

485

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

239

517

2.41

29.96

1.4

1.5

74.50

72.92

1.02

226

497

(3036180) Methadone [Presence] in Urine

13.64

29.70

3.2

1.6

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

11.69

29.68

5.0

1.5

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3453

14541

1.25

29.61

3.1

2.3

65.29

49.16

u/l

0.41

2925

12421

(3008536) Aspergillus sp Ab [Presence] in Serum

132

205

3.35

29.44

2.4

2.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

394

1056

1.95

29.36

1.4

1.2

2.31

2.82

u/ml

0.30

253

483

(3033658) Prothrombin time (PT) actual/Normal

9143

42170

1.16

29.33

5.1

3.6

91.03

89.61

5.82

8868

41285

(3001186) Copper [Moles/volume] in Serum or Plasma

177

332

2.77

29.20

1.4

1.2

16.38

16.43

umol/l

0.04

151

279

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

360

937

2.00

29.10

1.1

1.2

1.07

ratio

0.11

325

760

(40765096) Chromosome analysis panel by Banding

171

316

2.82

28.97

1.1

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

559

1686

1.73

28.78

1.3

1.2

55.39

54.47

u/ml

0.02

100

(3002079) Sodium [Moles/time] in 24 hour Urine

272

636

2.23

28.76

1.3

1.2

161.49

167.55

mmol/24h

0.48

272

636

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

103

137

3.91

28.31

1.2

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

209

437

2.49

28.13

1.0

8.68

10.48

u/ml

0.50

143

319

(3022493) Free Hemoglobin [Mass/volume] in Plasma

262

610

2.24

27.99

8.4

3.7

64.97

4213.32

mg/l

3.27

197

414

(3020393) Adenovirus Ag [Presence] in Stool

108

4.33

27.95

1.8

1.1

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

361

956

1.97

27.85

2.1

1.4

—

(44806420) Estimation of glomerular filtration rate

227

2491

0.47

27.82

2.4

2.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

211

446

2.46

27.79

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

5.35

27.78

2.4

2.1

0.70

0.61

ug/l

0.80

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

470

1367

1.79

27.37

1.2

64.73

68.77

u/l

0.38

431

1182

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

291

717

2.11

27.16

1.3

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

662

2128

1.62

26.94

1.8

1.6

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

366

989

1.93

26.70

1.5

1.3

13.28

12.50

u/l

0.71

351

963

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

110

162

3.53

26.50

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

183

370

2.57

26.35

1.3

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

5635

25200

1.18

26.23

3.8

2.7

3.26

2.80

e6/l

1.73

3240

10199

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

205

440

2.43

26.20

2.1

2.6

1.35

1.14

ug/l

0.39

194

416

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

6.61

25.96

3.8

1.3

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

209

456

2.39

25.82

2.1

1.8

173.07

168.75

0.20

201

425

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

877

3042

1.51

25.73

1.6

1.4

0.36

0.42

nmol/l

0.85

673

2392

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

5.36

25.56

1.0

0.56

0.34

u/ml

0.16

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

5.36

25.56

1.6

1.4

42.40

35.44

0.48

(3016228) CD19 cells/cells in Blood

230

527

2.27

25.54

2.4

1.9

8.86

7.32

0.90

223

515

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

794

2700

1.54

25.52

1.1

17.62

14.56

au/ml

0.46

172

900

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

683

2249

1.59

25.24

1.9

2.2

32.52

32.61

0.20

678

2234

(3017704) Immunofixation for Urine

234

546

2.23

24.94

1.7

1.5

—

(3024869) Neuronal Ab [Presence] in Serum

119

194

3.19

24.79

1.1

—

(3001556) Androgen free Index in Serum or Plasma

117

3.91

24.26

1.3

1.2

—

(4035726) Immunohistochemistry procedure

3264

13972

1.23

23.95

1.5

1.4

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

130

231

2.93

23.64

1.5

0.41

0.42

ug/l

0.10

174

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

149

287

2.70

23.56

1.6

1.5

9.34

9.47

ug/l

0.12

149

287

(44806071) Cardiolipin IgM antibody measurement

107

169

3.29

23.40

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

258

644

2.09

23.40

1.1

97.26

95.11

0.51

224

494

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1045

3826

1.43

23.36

2.2

0.04

0.02

g/l

0.98

945

3382

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

542

1722

1.64

23.17

1.2

1.1

96.47

97.64

0.42

518

1622

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

13.18

23.01

7.2

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

629

4949

0.65

22.75

1.5

59.11

61.03

ug/l

0.48

629

4949

(3003694) ABO and Rh group [Type] in Blood

11600

55118

1.13

22.75

1.5

—

(3016750) Collection duration of Urine

305

820

1.94

22.67

2.5

2.0

500.75

502.00

min

0.08

281

549

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

301

808

1.94

22.48

1.3

1.4

5.62

5.54

mmol/l

0.37

281

763

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

145

283

2.66

22.41

1.3

1.1

12.92

10.60

pmol/l

0.28

(3003329) Lymphocytes/Leukocytes in Synovial fluid

487

1518

1.67

22.40

1.5

29.25

32.25

0.99

298

935

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

226

545

2.16

22.35

3.0

2.4

146.40

143.83

au/ml

0.02

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

245

611

2.09

22.30

1.6

1.5

22.95

4.81

nmol/l

0.41

208

503

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

169

358

2.46

22.28

1.3

1.2

127.21

131.38

nmol/l

0.10

135

254

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

406

1207

1.75

22.10

1.2

—

(3051339) Copper [Moles/volume] in Blood

6.02

21.96

1.2

1.3

16.77

15.35

umol/l

0.91

(3045683) HLA typing for celiac disease panel - Blood or Tissue

311

852

1.90

21.91

1.0

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

363

1048

1.80

21.78

1.5

1.4

12.47

12.33

umol/l

0.15

346

994

(3024263) Appearance of Synovial fluid

242

607

2.08

21.72

2.4

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

985

3618

1.42

21.66

1.7

1.6

—

(40763590) HLA-DQ beta [Type]

7.14

21.66

1.0

—

(40760410) HLA-B [Type] by High resolution

6.88

21.54

1.0

—

(40760409) HLA-A [Type] by High resolution

6.88

21.54

1.0

—

(46236302) HLA-C [Type] by High resolution typing

6.88

21.54

1.0

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

119

3.67

21.41

2.2

1.5

1.26

1.31

umol/l

0.47

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1183

4495

1.38

21.39

1.3

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

153

3.30

21.30

3.5

2.9

40.16

46.19

umol/l

1.59

133

(3013862) HLA-DP [Type]

6.93

21.18

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

102

168

3.16

21.00

2.2

3.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

725

2527

1.50

20.88

2.5

2.2

7.00

6.17

umol/l

0.62

540

1853

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

181

409

2.30

20.85

3.4

2.3

0.61

mmol/l

0.09

181

409

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

133

3.44

20.56

1.2

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

100

166

3.13

20.36

1.9

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

529

4212

0.65

20.31

4.1

3.0

24.74

28.01

mg/l

1.27

321

2944

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

151

3.24

20.12

1.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

242

626

2.01

20.08

3.7

3.2

7.43

9.29

mg/l

3.48

210

482

(3033923) Metanephrine [Moles/time] in 24 hour Urine

107

188

2.96

19.91

1.1

0.66

0.96

umol/24h

0.42

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

7.50

19.90

1.0

—

(40768441) Liver Pathology biopsy report

353

1041

1.77

19.81

1.7

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

237

612

2.02

19.77

4.0

3.1

1.69

1.25

2.82

237

612

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

4.93

19.72

1.6

1.4

13.38

15.21

0.18

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

409

1260

1.69

19.72

4.7

5.7

134.99

82.10

u/ml

0.52

128

491

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

143

3.27

19.59

1.2

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3089

19031

0.83

19.57

3.7

3.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

143

298

2.50

19.56

1.1

—

(3034426) Prothrombin time (PT)

178

412

2.25

19.46

1.3

1.2

28.35

27.67

0.80

178

412

(3008116) Ketones [Moles/volume] in Urine by Test strip

141

294

2.49

19.27

1.9

1.2

0.11

0.35

mmol/l

2.43

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

874

6275

0.72

19.18

1.5

1.6

—

(3045142) Bone marrow Pathology biopsy report

450

1441

1.63

18.77

1.4

1.3

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

5.86

18.55

10.4

11.4

110.18

202.04

e6/l

0.88

(3010370) Gastrin [Moles/volume] in Serum or Plasma

100

177

2.94

18.42

2.4

1.6

47.14

53.26

pmol/l

0.21

153

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

107

3.59

18.42

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

880

6269

0.72

18.40

1.5

1.15

1.18

ratio

0.28

549

3604

(3043410) Blood group antigens tested for on Red Blood Cells

163

374

2.27

18.22

2.1

1.7

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

+∞

18.21

1.0

0.0

0.05

—

u/ml

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

305

884

1.80

18.17

1.2

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

14933

72604

1.10

18.14

2.0

1.8

1.46

1.35

mmol/l

26.64

13215

60722

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

886

6288

0.73

18.09

1.5

1.14

1.18

ratio

0.55

559

3644

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

886

6288

0.73

18.09

1.5

0.97

0.94

ratio

1.01

555

3623

(44813793) Dust mix specific IgE antibody measurement

353

1074

1.71

17.85

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

871

6181

0.73

17.78

1.5

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

136

293

2.41

17.45

1.2

80.12

75.54

0.35

(3018133) Calcium [Moles/volume] in Urine

115

228

2.62

17.38

2.5

1.6

2.62

2.78

mmol/l

0.32

108

212

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

216

567

1.98

17.31

2.2

1.9

8.51

9.49

mg/l

1.74

192

446

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

588

2043

1.50

17.29

1.6

1.4

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

4.72

17.21

1.0

1.03

3.06

u/ml

0.44

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

401

1276

1.64

17.20

1.3

—

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

4.80

17.16

1.5

1.3

1.16

0.94

0.16

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

137

299

2.38

17.12

1.2

87.49

84.02

0.26

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

249

690

1.88

17.10

1.2

19.47

19.92

u/ml

0.01

(3017315) Amylase [Enzymatic activity/volume] in Urine

296

867

1.78

17.08

1.3

1.2

284.32

368.49

u/l

0.66

278

817

(3020123) Porphyrins [Interpretation] in Serum or Plasma

5.08

17.06

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

965

3687

1.37

16.95

2.2

0.00

g/l

0.46

764

3221

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

110

216

2.65

16.94

1.2

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

133

3.17

16.85

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

181

449

2.10

16.85

1.4

326.91

296.81

nmol/24h

0.06

181

449

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

173

423

2.13

16.70

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

658

2356

1.46

16.69

1.4

1.3

7.12

6.94

mmol/l

0.82

606

2096

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.02

16.68

1.6

1.7

1.78

1.70

mg/l

0.04

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1863

7805

1.25

16.59

3.4

3.5

60.52

57.32

u/ml

0.07

1817

7579

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

275

798

1.79

16.38

1.4

1.5

10.92

6.33

u/l

4.04

236

587

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

4.08

16.13

1.4

1.6

18.97

19.39

nmol/l

0.02

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1934

12231

0.81

15.98

1.5

1.6

970.37

1018.16

mu/l

1.17

1661

10377

(3028717) Thiamine [Mass/volume] in Blood

155

2.92

15.92

1.2

1.1

62.91

63.80

ug/l

0.12

155

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.50

15.91

1.2

1.1

1.50

1.66

iu/ml

0.28

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.90

15.81

1.2

1.1

0.31

0.40

iu/ml

0.38

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

162

2.86

15.72

2.5

1.5

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

713

2622

1.42

15.72

1.2

1.1

11570.03

828.33

iu/ml

0.45

192

506

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

3.97

15.60

1.6

1.7

3.02

2.57

mg/l

0.17

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

3.97

15.60

1.6

1.7

1.92

3.38

mg/l

0.79

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

3.97

15.60

1.6

1.7

1.95

1.80

mg/l

0.06

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

3.97

15.60

1.6

1.7

1.76

1.73

mg/l

0.01

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

3.97

15.60

1.6

1.7

0.45

0.57

mg/l

0.24

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

3.97

15.60

1.6

1.7

4.16

3.42

mg/l

0.23

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

3.97

15.60

1.6

1.7

0.98

1.38

mg/l

0.26

(3014051) Protein [Presence] in Urine by Test strip

10074

48305

1.11

15.55

3.0

2.5

0.12

0.06

0.83

116

1039

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3.74

15.53

1.5

1.2

18.42

14.30

nmol/l

0.70

(3042631) Mycobacterium sp identified in Specimen

593

2113

1.46

15.46

2.8

2.4

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

3.91

15.35

1.6

1.7

2.79

1.07

mg/l

0.85

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

3.91

15.35

1.6

1.7

1.40

2.19

mg/l

0.61

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

109

3.29

15.25

1.1

1.2

39.77

48.81

mg/l

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

102

205

2.59

15.10

1.1

1.2

308.29

555.52

titre

—

(3036670) Protein [Mass/volume] in Synovial fluid

138

321

2.24

15.05

1.2

41.52

40.96

g/l

0.16

165

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

4.58

15.05

1.4

1.1

28.53

17.56

0.56

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

124

3.10

14.97

1.2

1.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

147

2.90

14.89

1.0

1.1

1.23

1.17

mom

0.27

147

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

122

3.11

14.84

1.2

1.0

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

347

1111

1.63

14.62

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

339

1083

1.63

14.41

1.1

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

111

239

2.41

14.35

1.4

1.3

20.14

23.08

0.50

196

(3000012) Reticulocyte production index

660

2439

1.41

14.21

2.0

2.2

0.93

0.90

0.67

465

1621

(3038071) Oxygen [Partial pressure] in Mixed venous blood

128

296

2.25

14.18

12.4

5.4

6.61

5.27

kpa

5.10

128

296

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

164

420

2.03

14.16

1.9

1.7

81.69

133.87

au/ml

0.80

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

3.36

14.14

1.0

1.2

0.50

6.65

u/ml

2.04

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.59

14.03

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1463

6080

1.26

14.02

1.5

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

507

1789

1.48

13.94

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

204

568

1.87

13.92

1.6

3456.00

3407.40

titre

0.02

100

(3004775) Volume in Urine collected for unspecified duration

339

1093

1.61

13.92

3.0

2.0

680.95

697.52

0.31

313

677

(3011841) English Walnut IgE Ab [Units/volume] in Serum

103

3.23

13.80

1.0

1.2

1.31

11.56

u/ml

2.14

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

5.06

13.70

1.3

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

4.45

13.65

1.8

1.2

199.22

227.47

ug/g

0.28

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

141

348

2.11

13.41

12.0

5.8

5.76

6.09

kpa

4.65

128

296

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

355

1171

1.58

13.30

1.2

1.1

—

(3006270) Folate [Moles/volume] in Blood

327

1058

1.61

13.27

1.2

1.1

349.14

394.85

nmol/l

3.03

307

902

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

3.23

13.21

1.4

9.34

21.01

pmol/l

1.32

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

331

1076

1.60

13.18

1.2

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.71

13.10

1.0

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

156

2.70

13.04

1.4

1.2

437.18

67.59

u/l

0.43

110

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

146

370

2.05

13.00

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

330

1076

1.60

12.99

1.2

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

163

2.65

12.90

1.2

1.3

29.59

47.72

mg/l

3.41

136

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1035

4172

1.29

12.71

2.3

131.78

131.28

g/l

0.26

844

3379

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

322

1051

1.59

12.64

1.7

4.23

3.76

mg/l

0.72

308

997

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

104

3.10

12.60

1.0

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

259

800

1.68

12.59

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

180

499

1.88

12.51

2.7

1.6

2626.48

2545.19

e6/l

0.01

152

295

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

319

1042

1.59

12.49

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

145

2.72

12.47

1.5

1.7

95243.94

479040.07

nmol/l

1.06

124

(3034891) Synovial lining cells/cells in Synovial fluid

264

822

1.67

12.46

1.4

3.71

4.57

0.27

203

(3013166) Neutrophils/Leukocytes in Synovial fluid

154

405

1.98

12.45

1.5

1.3

54.69

56.38

0.20

129

348

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

983

3948

1.30

12.42

1.1

2.47

2.42

u/ml

0.05

566

1919

(3009015) Lactate [Moles/volume] in Synovial fluid

3.34

12.28

1.2

1.3

5.80

5.88

mmol/l

0.03

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

601

2248

1.39

12.15

1.7

1.4

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

3.11

11.86

1.1

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

3.35

11.69

1.3

1.27

1.31

ml/s/173m2

0.05

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

114

274

2.16

11.64

2.7

2.9

413.02

913.77

ug/l

0.38

114

274

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

234

721

1.69

11.53

6.4

4.8

51.44

1539.67

u/ml

0.79

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

105

2.97

11.44

1.0

1.1

0.24

6.97

u/ml

0.63

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

13.27

11.42

1.0

1.1

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

110

263

2.17

11.39

1.6

1.5

5.78

6.01

nmol/l

0.17

105

256

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

3.60

11.37

1.0

1.1

2.70

4.43

u/l

—

(21491868) Cryoglobulin [Mass/volume] in Serum

171

482

1.84

11.35

1.3

1.2

0.17

0.22

g/l

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

168

472

1.85

11.27

2.4

1.9

1.94

1.69

ratio

0.95

160

459

(3002256) Pathology report gross observation

4825

22579

1.12

11.25

1.3

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

3.06

11.22

1.0

1.1

0.20

0.39

u/ml

0.28

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

3.37

11.10

3.2

2.9

27.94

68.33

pmol/l

0.38

(3020650) Glucose [Presence] in Urine

875

0.45

11.00

1.5

1.4

0.09

0.04

estimate

0.41

875

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

141

2.62

10.88

1.3

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

135

2.66

10.87

1.0

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

129

335

2.00

10.86

1.3

33.73

40.37

1.06

235

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

215

2.27

10.80

1.1

1.3

3.36

13.75

u/ml

1.89

136

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

106

2.89

10.80

1.0

1.1

0.11

1.51

u/ml

0.78

(3019174) dRVVT (LA screen)

2.97

10.70

1.2

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

5.63

10.67

2.4

2.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

490

1812

1.41

10.65

1.5

1.4

3484.36

2984.91

e6/l

0.20

394

1213

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

3.37

10.63

22.2

3.4

108.70

105.28

g/l

0.79

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

165

2.46

10.59

2.7

1.9

1.42

1.52

mmol/l

0.10

127

(3021367) Citalopram [Moles/volume] in Serum or Plasma

4.49

10.56

1.3

143.58

124.81

nmol/l

0.24

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

391

1391

1.46

10.47

1.4

1.3

369.40

483.28

u/l

1.44

370

1321

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

5.01

10.34

1.1

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

360

1264

1.48

10.30

1.2

1.1

—

(3022764) Mononuclear cells/Leukocytes in Peritoneal fluid

5.40

10.29

6.1

13.2

49.44

49.80

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

955

3920

1.27

10.27

1.3

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

428

1557

1.43

10.21

1.6

7.96

7.52

mmol/l

3.23

403

1503

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

170

496

1.78

10.17

4.9

2.2

4.93

4.92

kpa

0.06

170

496

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

170

496

1.78

10.17

4.9

2.2

10.47

10.39

kpa

0.13

170

496

(3044416) Complement C4 [Mass/volume] in Pleural fluid

3.72

10.08

1.5

1.2

0.07

0.08

g/l

0.17

(4094501) Cardiovascular stress test using bicycle ergometer

1023

4245

1.26

10.05

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

111

2.76

10.01

1.3

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

210

2.23

9.93

2.0

1.3

0.19

0.24

nmol/l

0.42

137

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1025

6584

0.80

9.91

1.5

1.6

63.72

62.70

ug/l

0.19

868

5421

(40758292) HTLV I+II Ab panel - Serum

119

311

1.99

9.90

1.4

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

131

355

1.92

9.85

1.3

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

185

2.30

9.76

1.5

1.3

174.67

64.28

mu/l

0.57

144

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

208

651

1.66

9.76

2.4

2.5

20.81

172.01

ug/l

0.88

201

621

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

310

1070

1.51

9.66

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

114

296

2.00

9.66

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.28

9.63

1.1

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

126

2.60

9.58

1.1

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

714

0.44

9.56

5.7

6.7

9.08

8.54

0.33

714

(40761995) Spermatozoa Progressive [#/volume] in Semen

714

0.44

9.56

2.9

3.4

42.90

45.28

0.40

714

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

524

3632

0.75

9.36

1.3

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

144

2.45

9.27

1.1

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

203

644

1.64

9.09

1.1

1.2

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

123

336

1.90

9.08

1.1

6.40

6.34

mg/g

0.04

118

324

(3003888) Timothy IgE Ab [Units/volume] in Serum

833

3420

1.27

9.00

1.1

4.80

5.63

u/ml

0.79

459

1706

(3017461) Flecainide [Moles/volume] in Serum or Plasma

3.40

8.97

1.7

1.5

0.61

0.76

umol/l

0.64

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

136

386

1.83

8.95

1.3

1.2

524.28

181.49

ug/l

0.63

200

(3001964) Herpes simplex virus Ag [Presence] in Specimen

131

369

1.85

8.84

1.9

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

232

2.08

8.79

1.4

1.3

—

(3018333) Ribosomal P Ab [Presence] in Serum

298

1045

1.48

8.67

1.2

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

4.50

8.64

1.6

907.80

2323.00

umol/l

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

3.37

8.64

2.4

2.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.96

8.63

2.1

1.6

51.98

44.86

umol/l

0.55

(3011897) Casein IgE Ab [Units/volume] in Serum

214

2.11

8.53

1.1

1.4

6.29

2.62

u/ml

0.28

208

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

821

3388

1.26

8.53

1.5

1.4

150.51

144.48

pmol/l

0.09

800

3319

(3003434) Protein [Mass/volume] in Pleural fluid

537

2096

1.33

8.48

1.5

1.4

86.64

33.51

g/l

0.48

506

1913

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.53

8.47

1.5

1.3

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

3.53

8.47

1.0

1.1

18.85

23.45

u/ml

0.14

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

444

1684

1.37

8.44

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.16

8.32

1.5

1.4

534.17

433.01

nmol/l

0.42

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

7064

34172

1.09

8.32

3.1

3.0

0.72

0.79

ug/l

8.76

4318

20500

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

457

1749

1.36

8.22

1.4

8.24

7.94

mmol/l

0.75

444

1668

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

169

526

1.67

8.19

1.1

2.80

8.57

u/ml

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

336

1221

1.43

8.18

4.0

3.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

326

1178

1.44

8.18

2.2

1.9

1.93

1.64

u/field

0.38

146

623

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

177

558

1.65

8.17

1.2

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

131

2.42

8.14

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

3.06

8.09

1.0

1.2

0.43

1.38

u/ml

0.36

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

209

2.09

8.04

1.6

1.3

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.07

7.95

3.5

3.6

—

(3026470) Cobalt [Mass/volume] in Blood

226

762

1.54

7.94

2.1

2.3

3.07

3.52

ug/l

0.28

211

709

(3026692) Albumin [Mass/volume] in Peritoneal fluid

128

372

1.79

7.88

1.7

1.2

13.06

13.25

g/l

0.08

100

280

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.76

7.86

1.5

1.4

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

4.09

7.79

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

983

4183

1.22

7.79

3.4

3.0

2.15

2.04

index

0.12

601

1984

(3012494) Peanut IgE Ab [Units/volume] in Serum

121

347

1.81

7.78

1.1

3.50

7.76

u/ml

0.71

206

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

112

315

1.85

7.66

1.3

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

132

2.36

7.64

3.8

1.9

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

101

2.57

7.55

1.0

1.1

9.48

12.00

u/l

0.38

101

(3047189) Immunofixation for 24 hour Urine

183

596

1.60

7.48

1.5

1.8

—

(37208534) Antinuclear antibody arbitrary concentration in serum

141

429

1.71

7.46

1.1

—

(3033086) Enterovirus Ab [Titer] in Serum

4.06

7.43

1.0

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

3.86

7.28

6.6

10.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

306

1120

1.42

7.23

1.3

1.2

21.07

14.19

u/l

0.66

280

1049

(3038515) Glucose [Moles/volume] in Venous blood

667

2745

1.27

7.17

2.7

2.8

7.12

7.75

mmol/l

4.75

648

2673

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

174

2.12

7.10

1.9

1.7

1.59

1.80

mg/l

0.54

143

(3034614) HLA Ag [Interpretation]

4.02

7.07

1.4

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

141

2.25

7.01

2.1

1.7

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

816

3446

1.23

7.01

2.3

0.00

g/l

-0.00

760

3215

(4133840) Spirometry

141

439

1.67

6.90

1.2

1.1

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

139

2.24

6.87

1.7

1.6

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

143

448

1.66

6.85

2.5

1.5

11832.98

12745.90

e6/l

0.05

196

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

195

2.02

6.79

1.8

1.5

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

171

2.10

6.74

11.0

6.9

0.40

0.30

umol/l

1.05

149

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.49

6.72

1.1

1.2

1.42

1.69

umol/24h

0.87

(3044009) aPTT.lupus sensitive (LA screen)

114

2.37

6.72

1.2

1.1

—

(3049233) Organic acids panel - Urine

8.31

6.66

1.2

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

104

301

1.80

6.57

1.2

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

227

1.92

6.53

1.4

1.2

321.96

324.35

pmol/l

0.02

176

(3002331) Protein [Mass/volume] in Peritoneal fluid

109

321

1.76

6.51

1.5

1.2

23.39

100.12

g/l

0.74

251

(4281824) Cell count and differential, peritoneal fluid

255

1861

0.71

6.51

1.3

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

104

302

1.79

6.51

1.9

1.5

40.59

33.40

u/l

0.18

273

(3020618) Glucose [Moles/volume] in Synovial fluid

3.42

6.50

1.0

1.1

5.21

4.88

mmol/l

0.23

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

104

303

1.78

6.44

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

104

303

1.78

6.44

1.2

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

218

767

1.48

6.39

1.3

1.2

104.89

89.79

u/l

0.66

185

652

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

151

2.13

6.35

1.1

1.0

0.02

0.42

u/ml

0.95

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

165

2.08

6.33

2.9

2.6

62.05

73.58

pmol/l

0.30

148

(3010726) Horse dander IgE Ab [Units/volume] in Serum

791

3368

1.22

6.33

1.1

1.95

2.00

u/ml

0.06

443

1508

(3035947) Staphylolysin Ab [Units/volume] in Serum

205

714

1.49

6.31

1.2

1.1

4.33

4.28

iu/ml

0.02

(3051101) Glucose [Moles/volume] in Cord blood

292

0.30

6.27

4.4

6.0

8.14

8.40

mmol/l

0.17

292

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

227

809

1.46

6.25

6.7

8.0

121.75

36.05

ug/l

0.59

151

566

(37019676) Renin [Units/volume] in Plasma --supine

4.90

6.20

1.1

1.0

87.08

24.42

mu/l

0.63

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.92

6.09

5.0

4.2

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

12.46

6.06

1.1

1.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

313

1189

1.37

6.05

1.1

7.40

8.13

iu/ml

0.21

391

(3025577) Chromium [Mass/volume] in Blood

213

755

1.47

6.04

2.1

2.3

2.30

ug/l

0.00

172

649

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

141

456

1.61

6.03

1.1

1.0

—

(3021788) Differential panel - Synovial fluid

701

2964

1.23

6.02

1.6

1.5

1.00

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

304

1151

1.37

6.00

1.3

1.2

171.36

204.85

titre

0.27

167

(3041672) Baker's yeast Ab [Presence] in Serum

3.29

5.96

1.0

1.1

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

303

1148

1.37

5.96

1.3

1.2

165.00

161.56

titre

0.01

(40762814) Titanium [Mass/volume] in Blood

177

2.00

5.91

2.7

2.6

3.32

3.54

ug/l

0.19

(3002619) Bacteria identified in Specimen by Culture

122

385

1.65

5.76

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

204

1508

0.70

5.69

2.6

2.1

1.20

mmol/l

0.35

204

1493

(4034850) Laboratory test

1108

6695

0.86

5.68

11.4

8.3

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

4.25

5.68

3.6

4.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.53

5.66

1.1

1.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1163

5188

1.17

5.61

3.2

3.8

817.82

3357.31

u/ml

1.23

1015

4495

(1616796) Gas panel - Central venous blood

957

4204

1.19

5.56

3.8

3.6

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

284

1.74

5.47

1.4

1.2

1.44

1.66

mmol/l

1.09

167

(3008401) Mugwort IgE Ab [Units/volume] in Serum

775

3346

1.21

5.46

1.1

0.79

1.12

u/ml

1.22

332

1350

(3011648) Oxygen content in Venous blood

419

1689

1.29

5.44

4.9

1.9

11.51

11.10

1.20

419

1683

(3021162) Amylase [Enzymatic activity/volume] in Specimen

250

1.79

5.44

2.9

3.0

2247.69

1665.91

u/l

0.17

226

(40759632) Porphyrins [Mass/mass] in Stool

11.42

5.42

1.0

1.2

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

8.90

5.29

1.1

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

189

1.90

5.25

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

227

1.81

5.20

1.2

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

408

1651

1.29

5.17

1.5

1.4

50708.10

49181.90

e6/l

0.05

260

883

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

565

2377

1.24

5.16

1.1

3.21

2.74

eliau/ml

0.33

254

1338

(3029612) Listeria sp Ab [Titer] in Serum

4.58

5.13

1.3

1.2

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

102

2.24

5.13

1.0

1.1

0.26

1.88

u/ml

1.27

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

162

1.96

5.08

2.7

2.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

701

3021

1.21

5.07

1.1

3.90

4.16

u/ml

0.14

394

1401

(40762887) Creatinine [Moles/volume] in Blood

2.56

5.05

1.5

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

208

762

1.42

5.05

1.2

—

(3022806) Fractional oxyhemoglobin in Capillary blood

349

2332

0.77

4.98

2.1

1.7

89.84

89.65

0.23

343

2295

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

2.35

4.92

1.3

1.2

343.03

306.46

u/l

0.05

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

2.64

4.88

1.1

21.52

20.23

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

2.64

4.88

1.1

57.43

14.18

u/ml

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

203

747

1.41

4.83

1.3

1.2

31.61

25.51

u/l

0.49

171

626

(3042010) Triglyceride [Moles/volume] in Pleural fluid

222

1.78

4.79

1.4

1.2

0.77

1.27

mmol/l

0.65

137

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

137

2.01

4.77

3.7

2.5

1.77

1.28

mg/l

0.48

(3041806) Other cells [#/volume] in Blood by Manual count

121

951

0.66

4.76

1.6

1.4

0.51

e9/l

0.02

121

951

(3027231) Wheat IgE Ab [Units/volume] in Serum

289

1.67

4.74

1.0

1.1

9.65

0.77

u/ml

0.60

275

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

5.59

4.70

1.2

1.1

1.49

1.38

mg/l

0.12

(3027696) Helicobacter pylori Ab [Titer] in Serum

8.16

4.69

1.1

1.0

1392.73

1378.57

titre

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

3.09

4.64

1.1

1.0

247.50

214.29

pmol/l

0.14

(3020491) Glucose [Moles/volume] in Blood

280

1094

1.33

4.63

1.8

1.9

6.89

6.73

mmol/l

0.34

218

885

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.36

4.60

1.1

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

3.01

4.46

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

346

1408

1.28

4.28

2.4

1.7

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

212

805

1.37

4.25

1.1

165.97

227.74

iu/ml

2.40

212

795

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

216

1.73

4.20

6.5

6.1

10.75

10.73

0.03

216

(3017958) Strawberry IgE Ab [Units/volume] in Serum

3.05

4.17

1.0

0.01

0.06

u/ml

—

(3000330) Specific gravity of Urine by Test strip

1410

6520

1.13

4.16

3.0

2.9

1.02

ratio

12.97

1287

5659

(40761539) Cells [Type] in Urine sediment by Light microscopy

113

382

1.54

4.16

1.2

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.95

4.15

1.0

1.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.18

4.13

1.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

3.39

4.12

1.7

1.2

2.02

2.35

mmol/24h

0.30

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

102

2.09

4.12

1.5

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1342

6194

1.13

4.09

1.5

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

310

1.59

4.07

1.2

92.18

55.07

mg/l

0.28

217

(3000285) Sodium [Moles/volume] in Blood

239

1.67

4.00

1.4

1.2

137.82

138.67

mmol/l

0.82

203

(3045191) Normetanephrine [Moles/volume] in Urine

+∞

3.96

1.2

0.0

2.20

—

umol/l

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

248

1.65

3.95

2.1

2.0

1.95

4.41

ug/l

0.75

168

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2377

11352

1.09

3.80

11.3

7.4

24.83

24.72

mmol/l

0.75

2365

11251

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

2.08

3.79

1.0

1.1

4.17

8.04

u/ml

0.76

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

2.27

3.79

1.0

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

329

1.55

3.76

1.2

1.1

—

(3013290) Carbon dioxide [Partial pressure] in Blood

709

4281

0.86

3.75

4.5

3.7

5.06

5.00

kpa

1.45

695

4185

(3012501) Base excess in Blood by calculation

709

4281

0.86

3.75

4.5

3.7

2.50

2.49

mmol/l

0.03

464

2877

(3018738) Hemoglobin F/Hemoglobin.total in Blood

100

2.03

3.66

3.0

2.1

15.36

16.86

0.09

(3036782) Glucose [Moles/volume] in Pleural fluid

380

1597

1.24

3.65

1.4

1.3

6.44

6.06

mmol/l

1.89

352

1489

(3032868) Hemoglobin electrophoresis panel in Blood

145

1.83

3.59

1.3

1.5

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

3.75

3.59

1.0

1.1

—

(3038413) Eosinophils/Leukocytes in Peritoneal dialysis fluid by Manual count

8.31

3.56

4.9

8.0

9.00

3.80

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

3.04

3.55

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

164

1152

0.74

3.52

1.4

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

3.46

3.50

1.0

0.10

0.01

u/ml

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

713

3190

1.16

3.49

1.4

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

713

3191

1.16

3.47

1.4

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

128

1.87

3.47

1.2

0.08

0.34

u/ml

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

218

1.64

3.42

1.0

88.99

77.76

ug/l

1.25

177

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

5.19

3.34

1.0

1.1

0.01

1.50

u/ml

—

(3025130) Human papilloma virus identified in Specimen

479

2953

0.84

3.33

1.8

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

134

1.82

3.31

1.0

1.1

0.38

0.54

u/ml

0.42

(3016031) Almond IgE Ab [Units/volume] in Serum

101

1.95

3.28

1.1

0.47

1.29

u/ml

1.50

(3035880) pH of Pleural fluid

209

833

1.30

3.15

1.3

1.2

7.42

7.40

0.77

161

550

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

173

672

1.34

3.12

1.2

1.3

992.11

1075.17

titre

0.36

149

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

181

1229

0.76

3.10

1.4

—

(3027315) Oxygen [Partial pressure] in Blood

723

4291

0.87

3.09

4.5

3.7

8.64

8.65

kpa

0.01

708

4195

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

2.60

3.08

2.1

2.4

303.89

211.53

ug/l

0.80

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

575

2559

1.17

3.06

1.1

1.0

0.43

0.46

u/ml

0.05

205

622

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

161

621

1.35

3.05

2.0

2.2

82.02

135.35

ug/min

0.46

118

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

173

1178

0.76

3.04

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

226

916

1.28

3.02

2.1

1.8

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

29754

156221

0.96

3.02

25.8

14.8

332.76

333.11

g/l

8.78

29552

155170

(3005532) Lymphocytes/Leukocytes in Pleural fluid

144

547

1.37

3.01

1.4

64.68

63.37

0.17

121

465

(1761482) Bacteria [#/volume] in Urine by Culture

564

3397

0.86

2.98

3.3

—

(3036525) Urea [Moles/time] in 24 hour Urine

105

1.88

2.97

3.3

2.8

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.21

2.96

2.5

2.7

3.57

1.79

mu/l

0.46

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

3.21

2.96

1.0

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

3.21

2.96

1.0

—

(3014891) Appearance of Pleural fluid

151

1.72

2.96

2.0

1.5

—

(3033942) Copper [Moles/time] in 24 hour Urine

2.37

2.88

1.1

0.23

0.42

umol/24h

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

107

1.84

2.83

1.3

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

489

2165

1.17

2.81

6.2

5.7

7.41

7.08

mmol/l

1.00

420

1798

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.00

2.79

1.1

1.0

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

3.07

2.78

1.2

1.1

32.44

33.36

0.05

(3007700) Barley IgE Ab [Units/volume] in Serum

2.11

2.77

1.0

0.10

0.16

u/ml

—

(3018001) Oat IgE Ab [Units/volume] in Serum

1.96

2.76

1.0

0.08

0.29

u/ml

0.75

(40765089) Chromosome analysis panel - Blood by G-banded

179

714

1.30

2.74

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.90

2.71

1.2

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

6.06

2.70

1.0

1.2

12.29

24.83

umol/l

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

159

628

1.32

2.63

1.8

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

159

628

1.32

2.63

1.8

1.3

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

3.11

2.63

1.2

1.1

—

(3042301) Urate [Moles/volume] in Synovial fluid

3.11

2.63

1.0

430.71

353.18

umol/l

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

2.80

2.60

1.3

1.1

73.73

63.69

1.64

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

190

1.59

2.58

1.1

14.58

28.77

iu/ml

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

747

3439

1.13

2.53

1.8

1.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

300

1285

1.21

2.53

1.1

20.34

20.54

u/ml

0.02

113

562

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.26

2.51

1.2

1.0

—

mmol/l

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

1.90

2.47

1.1

79.00

48.19

u/l

0.30

(3022670) pH of Venous cord blood

2.29

2.47

1.2

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

109

1.76

2.44

1.0

1.1

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

2.34

2.43

6.1

5.4

1.02

1.63

mg/l

0.80

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.99

2.42

1.1

—

(40768793) Breast Pathology biopsy report

801

3717

1.12

2.40

1.3

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

122

1.70

2.35

1.0

1.1

324.00

322.03

u/ml

0.01

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

385

2329

0.86

2.26

3.7

3.6

40.79

43.62

u/ml

0.11

375

2242

(3050794) Legionella sp Ab [Presence] in Serum

132

1.65

2.24

1.2

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.43

2.21

1.0

—

(40768800) Prostate Pathology biopsy report

582

3414

0.88

2.20

1.2

—

(3041184) Isoniazid [Presence] in Urine

3.78

2.19

3.0

2.1

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

2.71

2.14

1.0

0.49

0.12

u/ml

—

(3035320) C reactive protein [Mass/volume] in Body fluid

312

1369

1.18

2.10

3.1

2.2

27.94

28.59

mg/l

0.10

228

971

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

246

1532

0.83

2.07

1.4

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

100

1.71

2.03

1.0

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

242

1.44

1.99

1.4

15.48

10.56

0.57

141

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.72

1.98

2.1

30.34

25.90

0.32

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

159

656

1.26

1.98

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.73

1.97

1.3

1.5

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

335

1.36

1.95

2.3

2.7

7.21

7.24

mmol/l

0.03

169

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.08

1.91

1.1

1.3

28.93

33.04

mg/24h

0.43

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

2.19

1.91

1.5

1.2

—

(3001729) Color of Synovial fluid

127

0.45

1.90

2.6

1.6

—

(3036603) Volume of Urine

248

1078

1.20

1.89

1.5

1.6

2126.29

1964.11

1.19

243

1064

(40758358) Immune stain study

2.10

1.86

1.0

—

(3013762) Body weight Measured

2.27

1.82

1.1

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

489

2247

1.13

1.82

1.8

1.4

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.05

1.77

12.8

8.3

—

(3035285) Chloride [Moles/volume] in Venous blood

247

1512

0.85

1.76

2.3

2.1

104.62

105.52

mmol/l

1.85

247

1496

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

154

1.52

1.76

1.2

1.1

15.43

20.73

u/l

1.74

102

(3007456) Orange IgE Ab [Units/volume] in Serum

2.20

1.72

1.0

0.09

0.08

u/ml

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.25

1.67

1.1

1.6

134.46

30.93

umol/24h

0.43

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

353

1599

1.15

1.66

1.4

1.3

185.21

200.39

pmol/l

0.20

353

1599

(3023430) Cat dander IgE Ab [Units/volume] in Serum

621

2914

1.11

1.64

1.1

5.80

5.54

u/ml

0.09

303

1227

(3041354) Potassium [Moles/volume] in Venous blood

249

1512

0.85

1.64

2.3

2.1

4.05

4.07

mmol/l

0.24

249

1497

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.77

1.64

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.77

1.64

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.77

1.64

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.77

1.64

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.77

1.64

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.77

1.64

2.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.65

1.62

1.1

1.5

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

3.46

1.62

1.5

1.0

—

(3044007) Cell count panel - Peritoneal fluid

114

465

1.27

1.62

2.3

1.6

—

(3045788) Cell count panel - Pleural fluid

338

1535

1.14

1.56

1.5

1.4

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.47

1.55

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

2.08

1.52

4.0

5.9

0.34

0.21

mmol/l

0.62

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.62

1.52

1.7

1.3

313.66

324.49

umol/24h

0.11

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

378

1.29

1.51

3.1

2.4

95.37

100.10

ng/l

0.12

186

(40768795) Lymph node Pathology biopsy report

297

1765

0.87

1.49

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

122

508

1.25

1.49

1.1

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

161

1.45

1.47

2.7

2.1

66.50

58.53

0.58

100

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

103

1.56

1.42

5.4

—

(3046861) Legionella sp Ag [Presence] in Urine

145

0.57

1.38

1.0

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.58

1.36

1.4

1.5

—

(3032641) Amino acids panel - Urine

2.60

1.35

1.4

1.2

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

3.24

1.34

1.2

1.1

37.98

47.90

nmol/24h

—

(3043614) Bacteria identified in Aspirate by Culture

3.24

1.34

1.0

1.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

187

823

1.18

1.34

1.7

1.8

1.87

3.52

u/ml

0.84

246

(3024316) Viscosity of Plasma

1.66

1.34

1.3

2.0

1.44

1.97

mpas

2.18

(3002523) Influenza virus A Ag [Presence] in Specimen

695

3915

0.92

1.33

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.59

1.29

1.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

594

2822

1.09

1.29

1.2

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

1.60

1.29

1.0

0.03

0.24

u/ml

—

(3003740) Influenza virus B Ag [Presence] in Specimen

696

3914

0.92

1.29

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

123

1.48

1.28

2.0

3.0

0.51

0.49

u/field

0.05

123

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

193

1.37

1.27

1.1

1.2

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

1.81

1.23

1.0

0.30

0.06

u/ml

—

(3001218) Citrate [Mass/time] in 24 hour Urine

2.01

1.23

1.6

1.4

443.50

408.19

mg/24h

0.12

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

224

1334

0.87

1.22

1.3

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

532

3010

0.92

1.17

3.1

2.3

13.14

13.12

0.22

526

2966

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.77

1.16

1.1

0.08

2.28

u/ml

1.36

(3000919) Neutrophils/Leukocytes in Pleural fluid

106

450

1.22

1.15

1.3

1.4

21.77

22.07

0.04

410

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

292

1701

0.89

1.14

1.5

1.6

—

(3029396) Erythrocyte agglutination [Presence] in Blood

146

641

1.18

1.13

3.0

3.1

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.64

1.10

1.4

1.5

0.22

0.35

u/l

—

(3020874) Milk IgE Ab [Units/volume] in Serum

213

1259

0.88

1.07

1.1

0.99

2.09

u/ml

0.82

349

(4212803) Bone marrow aspirate examination

121

0.60

1.06

1.3

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

414

0.79

1.04

1.0

1.1

44.58

30.26

iu/ml

0.78

414

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

1.70

1.04

1.0

1.1

—

(44786800) Granulocytes/Leukocytes in Body fluid

183

1.33

1.03

1.4

22.57

24.35

0.12

139

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

268

1.26

0.96

1.0

1.1

14.87

8.63

u/ml

0.44

268

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.58

0.93

1.3

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

182

1.31

0.93

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

156

707

1.15

0.87

1.2

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.45

0.86

1.3

1.5

—

(3018291) Platelet Ab [Presence] in Serum

1.78

0.85

1.1

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

200

926

1.12

0.81

1.2

10.11

9.82

mm/h

0.11

200

926

(3009677) Dengue virus Ab [Presence] in Serum

1.48

0.81

1.2

1.1

—

(3012565) Volume of 24 hour Urine

158

929

0.88

0.80

2.2

2021.81

2010.04

0.04

151

851

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

247

1.24

0.80

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.60

0.78

1.1

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

216

1244

0.90

0.78

1.1

2.70

5.13

u/ml

0.30

284

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.43

0.75

1.0

1.1

1.16

4.09

u/ml

1.05

(3022475) Manganese [Moles/volume] in Blood

1.38

0.72

1.1

1.2

0.19

0.15

umol/l

1.88

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.61

0.72

1.0

5.06

1.17

u/ml

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

248

1173

1.10

0.71

1.9

1.7

47.20

881.02

pmol/l

0.81

147

(3015076) Soybean IgE Ab [Units/volume] in Serum

205

1175

0.91

0.70

1.0

1.1

0.57

0.77

u/ml

0.34

229

(3051611) Lipemic interference index of Serum or Plasma

293

1399

1.09

0.69

4.2

3.2

15.07

13.24

index

1.34

221

770

(3001019) Free T4 and TSH panel - Serum or Plasma

1903

10191

0.97

0.69

1.7

1.6

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

143

0.73

0.67

3.6

1.9

7.90

19.33

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

119

1.31

0.64

1.3

1.2

69.24

107.17

ug/l

1.09

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.51

0.64

1.1

1.2

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.64

0.0

1.1

—

(3026820) Hemoglobin [Mass/volume] in Venous cord blood

0.00

0.64

0.0

1.0

—

172.00

—

(3015350) Toxocara sp Ab [Presence] in Serum

1.64

0.56

1.0

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.54

0.55

1.5

1.0

205.36

246.83

u/ml

0.35

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.57

0.54

1.1

82.20

93.62

u/ml

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.56

0.53

1.2

1.1

2167.67

3845.45

titre

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.67

0.52

1.0

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.65

0.51

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

209

1.19

0.51

2.5

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

257

1.17

0.51

4.2

5.3

48.77

47.36

ug/min

0.06

207

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

476

2347

1.05

0.50

1.4

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

162

1.22

0.50

1.6

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1006

5051

1.03

0.47

1.2

1.1

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

1.73

0.45

1.2

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

1.62

0.43

1.4

1.1

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.43

0.0

1.2

—

1.81

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.43

0.0

1.1

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.43

0.0

1.1

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.42

0.0

1.0

—

(46235168) Fasting glucose [Moles/volume] in Blood

254

0.86

0.40

1.3

2.1

9.36

7.03

mmol/l

—

(40768806) Pleura Pathology biopsy report

343

1692

1.05

0.39

1.5

—

(3003157) Bacteria [#/volume] in Mother's milk

1.37

0.39

6.2

6.0

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

218

0.86

0.36

1.7

1.6

119.54

113.01

ug/l

0.11

177

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

218

0.86

0.36

1.3

6.08

5.83

mmol/l

0.78

218

(1617658) Protocol used for examination of sentinel lymph nodes

206

1136

0.94

0.35

1.0

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

136

1.18

0.34

1.2

1.1

15.33

17.20

iu/ml

—

(3010937) Rubella virus Ab [Presence] in Serum

133

0.82

0.34

1.0

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

811

4093

1.03

0.32

3.0

2.5

16.72

16.63

0.34

793

4005

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.40

0.32

1.0

1.1

2.86

2.58

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.40

0.32

1.0

1.2

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.30

0.31

1.4

1.0

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

1.30

0.28

1.0

1.88

0.07

u/ml

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

164

1.14

0.27

1.2

—

(3004959) Base excess in Arterial cord blood by calculation

140

1.15

0.26

1.1

1.0

-0.18

-1.57

mmol/l

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

136

1.15

0.24

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.37

0.24

1.0

1.1

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.30

0.23

1.2

1.0

2.20

1.40

—

(4038314) Semen analysis, post vasectomy

181

1.12

0.23

1.2

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.75

0.22

1.0

169.88

165.64

g/l

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

282

1.09

0.21

2.3

2.6

24.24

33.65

mg/l

0.53

(3004451) EKG impression Narrative

174

944

0.96

0.21

1.3

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1411

7431

0.99

0.21

1.5

1.4

—

(3006598) pH of Arterial cord blood

143

1.13

0.21

1.1

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.25

0.20

1.0

1.1

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.25

0.20

2.2

2.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

253

1.09

0.20

1.2

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

1.19

0.20

1.0

1.1

2.73

0.93

u/field

0.53

(3001893) Eosinophils/Leukocytes in Pleural fluid

105

519

1.05

0.16

1.4

3.84

2.39

0.76

445

(40763791) Oxygen content in Venous blood by calculation

0.83

0.14

3.5

6.0

13.16

11.74

ml/dl

—

(3011325) HIV 1+2 Ab [Presence] in Serum

100

0.88

0.14

1.2

1.0

0.08

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

605

3092

1.02

0.13

1.4

1.3

3.94

3.98

ug/l

0.02

544

2824

(3003577) Lead [Moles/volume] in Blood

174

1.07

0.11

1.4

1.6

0.28

0.40

umol/l

0.24

(3006462) Nitrate [Presence] in Urine

125

670

0.97

0.11

4.0

2.4

—

(3010421) pH of Blood

1179

6064

1.01

0.11

4.2

3.4

7.40

7.41

13.35

1166

5978

(3028271) Lactate [Moles/volume] in Capillary blood

579

3042

0.99

0.09

2.1

1.7

1.77

1.78

mmol/l

0.07

567

2962

(3005082) Progesterone [Moles/volume] in Serum or Plasma

242

1279

0.98

0.08

1.5

1.4

36.76

34.39

nmol/l

0.20

214

1199

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.04

0.08

1.3

1.0

—

(4211845) Urine protein measurement

138

734

0.98

0.08

3.8

2.4

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

259

1.04

0.07

1.1

1.2

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.92

0.07

1.1

1.2

14003.00

3186.41

ng/l

—

(3011544) Albumin [Mass/volume] in Pleural fluid

196

0.95

0.06

1.1

1.2

16.35

17.88

g/l

0.59

180

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.08

0.05

1.0

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

125

0.96

0.03

1.1

101.57

91.39

titre

0.17

125

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.02

0.00

1.1

1.2

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.06

0.00

1.0

1.1

216.70

270.84

nmol/l

—

(3035082) Kappa light chains [Mass/volume] in Urine

1.04

0.00

1.2

1.1

0.02

0.25

g/l

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

106

1.03

0.00

1.0

1.1

1.27

1.15

u/field

0.25

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

115

0.99

0.00

1.1

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

121

0.99

0.00

1.0

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

-0.00

0.0

2.8

—

3.40

—

(3035963) Corticotropin [Moles/volume] in Plasma

0.00

-0.00

0.0

1.0

—

10.68

—

(3003195) risperiDONE [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

3.92

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: Z21_GENERAL_EXAM_INVES_PERSONS_WO_COMPLA_REPOR_DIAGNOSIS – General examination and investigation of persons without complaint and reported diagnosis

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

General examination and investigation of persons without complaint and reported diagnosis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for General examination and investigation of persons without complaint and reported diagnosis (Z21_GENERAL_EXAM_INVES_PERSONS_WO_COMPLA_REPOR_DIAGNOSIS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints